| D |
| da Cunha V. |
- |
A NOVEL P2Y12 ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONIST THAT INHIBITS PLATELET AGGREGATION AND THROMBUS FORMATION IN RAT AND DOG MODELS |
| Da Representacao S. |
- |
COMPARISON BETWEEN CONVENTIONAL AND AUTOMATED METHODS OF RISTOCETIN COFACTOR ACTIVITY AND VON WILLEBRAND FACTOR ANTIGEN |
| Dachary-Prigent J. |
- |
THE RAPID PROCOAGULANT MEMBRANE SCRAMBLING INDUCED BY CALCIUM IONOPHORES IN PLATELETS AND LYMPHOCYTES IS DIFFERENT FROM THAT INDUCED BY THAPSIGARGIN IN PLATELETS: DEMONSTRATION WITH CYCLOSPORIN A |
| Dadgar J. |
- |
HEREDITARY THROMBOPHILIC DEFECTS IN IRANIAN PATIENTS WITH CEREBRO VASCULAR ACCIDENT |
| Dadoun F. |
- |
DISRUPTION OF PAI-1 CIRCADIAN RHYTHM IN OBESE SUBJECTS MAY EXPLAIN A CHANGE IN THE TIME OF ONSET OF MYOCARDIAL INFARCTION |
| Daemen M.J.A.P. |
- |
MOLECULAR IMAGING OF THROMBI USING A BIMODAL A2-ANTIPLASMIN-BASED CONTRAST AGENT |
| |
- |
LOCALISATION OF COAGULATION PROTEINS WITHIN THE ARTERIAL VESSEL WALL IN RELATION TO PROGRESSION OF ATHEROSCLEROSIS |
| Daemgen-von-Brevern G. |
- |
ALTERNATIVE ANTICOAGULATION WITH FONDAPARINUX IN PREGNANT PATIENTS WITH HEPARIN-INTOLERANCE |
| Dager W. |
- |
IMPROVING PATIENT SAFETY WHEN STARTING WARFARIN IN THE HOSPITAL: THE WARFDOCS STUDY |
| |
- |
EXPLORING ADULT PATIENT POPULATIONS AT RISK FOR DEVELOPING HIT |
| |
- |
SUCCESSFUL ANTICOAGULATION OF INFANTS TO ADULTS WITH BIVALIRUDIN IN EXTRACORPOREAL MEMBRANOUS OXYGENATION (EMCO) |
| Dager W.E. |
- |
LOW-DOSE (1.2MG) RFVIIA TO REVERSE WARFARIN THERAPY IN CRITICALLY ILL PATIENTS WITH MAJOR BLEEDING |
| |
- |
COMPARISON OF PRE-TEST PROBABILITY SCORES TO COMMERCIAL ASSAYS FOR MEASURING ANTIBODIES ASSOCIATED WITH HEPARIN-INDUCED THROMBOCYTOPENIA |
| Dahan K. |
- |
PROPOSITION FOR A MULTI-STEP MUTATION DETECTION IN HAEMOPHILIA A |
| Dahl O.E. |
- |
PREVENTION OF VENOUS THROMBOEMBOLISM VIA PARTIAL FACTOR IXA INHIBITION |
| |
- |
LACK OF EFFECT ON MARKERS OF THROMBIN GENERATION AND FIBRINOLYSIS BY PARTIAL FACTOR IXA INHIBITION FOLLOWING HIP FRACTURE SURGERY |
| |
- |
DABIGATRAN ETEXILATE IS EFFECTIVE AND SAFE FOR THE EXTENDED PREVENTION OF VENOUS THROMBOEMBOLISM FOLLOWING TOTAL HIP REPLACEMENT |
| |
- |
ASSOCIATION BETWEEN ASYMPTOMATIC DEEP-VEIN THROMBOSIS DETECTED BY SCREENING VENOGRAPHY AND SYMPTOMATIC VENOUS THROMBOEMBOLISM IN PATIENTS UNDERGOING ELECTIVE HIP OR KNEE SURGERY A SYSTEMATIC REVIEW |
| |
- |
CONTROVERSIAL ISSUES REGARDING THROMBOPROPHYLAXIS IN SURGICAL PATIENTS |
| Dahlbäck B. |
- |
REGULATION OF BLOOD COAGULATION BY THE PROTEIN C PATHWAY |
| Dahlback B. |
- |
DYSREGULATION OF ALTERNATIVE SPLICING OF COAGULATION FACTOR V RESULTS IN BLEEDING DISORDER, EAST TEXAS TYPE (OMIM 605913) |
| Dahlbäck B. |
- |
THE ROLE OF THROMBIN EXOSITES I AND II IN THE ACTIVATION OF HUMAN COAGULATION FACTOR V |
| |
- |
PROTEIN S-C4BP COMPLEX STIMULATES ACTIVATED PROTEIN C-MEDIATED INACTIVATION AT R306 BUT INHIBITS INACTIVATION AT R506 IN FACTOR VA |
| Dai L. |
- |
PROTEOMIC ANALYSIS OF PLASMA FROM HAEMOPHILIA A PATIENTS AFTER FACTOR VIII CONCENTRATE INFUSION |
| |
- |
THE FIRST CAUSATIVE MUTATION OF HAEMOPHILIA A IDENTIFIED IN THE PROMOTER REGION OF THE FACTOR VIII GENE (F8) |
| Daidone V. |
- |
POLYMORPHISMS OF VON WILLEBRAND FACTOR (VWF) GENE PROMOTER MODULATE THE CORTICOSTEROID-MEDIATED INCREASE IN VWF LEVELS IN CUSHING'S SYNDROME: A POTENTIAL MODEL OF TRANSCRIPTIONAL REGULATION AND A NEW THROMBOTIC MARKER |
| |
- |
A TYPE VICENZA-LIKE VON WILLEBRAND DISEASE NOT ASSOCIATED WITH VWF GENE MUTATION NOR ANTI-VWF ANTIBODIES |
| Daily C. |
- |
SYMPTOMATIC THROMBOSIS COMPLICATIONS IN VENOUS MALFORMATION |
| Dal-Cortivo L. |
- |
BONE MARROW-DERIVED MONONUCLEAR CELL THERAPY INDUCES DISTAL ANGIOGENESIS AFTER LOCAL INJECTION IN CRITICAL LEG ISCHEMIA |
| Dale C. |
- |
LABORATORY DIAGNOSIS OF HEPARIN INDUCED THROMBOCYTOPENIA: HELP OR HINDRANCE? |
| |
- |
CLINICAL DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA |
| Daleskog M. |
- |
INCREASED PLATELET PROCOAGULANT ACTIVITY IN TYPE 2 DIABETIC PATIENTS: INHIBITION BY GPIIB/IIIA BLOCKADE |
| Dali D.A. |
- |
SEVERE HYPOFIBRINOGENEMIA ASSOCIATED WITH MIDDLE CEREBRAL ARTERIAL THROMBOSIS |
| Dalla Pozza A. |
- |
BENIGN OUTCOME OF OBJECTIVELY PROVEN SPONTANEOUS RECANALIZATION OF INTERNAL CAROTID ARTERY OCCLUSION: LONG-TERM FOLLOW UP |
| Dalla Valle F. |
- |
D-DIMER AS AN ADJUNCT TO COMPRESSION ULTRASONOGRAPHY IN PATIENTS WITH SUSPECTED RECURRENT IPSILATERAL DEEP VEIN THROMBOSIS. A PROSPECTIVE COHORT STUDY |
| |
- |
THROMBOPHILIA AS A PREDICTOR OF RESIDUAL VEIN THROMBOSIS. A PROSPECTIVE COHORT STUDY |
| D'Alleva A. |
- |
SURGICAL BLEEDING AFTER PREOPERATIVE UNFRACTIONATED HEPARIN AND LOW MOLECULAR WEIGHT HEPARIN AT CORONARY BYPASS SURGERY |
| Dallongeville J. |
- |
METABOLIC SYNDROME, PAI-1 AND COLLATERAL VESSEL FORMATION IN PATIENTS WITH DOCUMENTED OCCLUDED CORONARY ARTERIES |
| Dall'Osso C. |
- |
ALTERNATIVE SPLICING AND NONSENSE-MEDIATED DECAY IN THE F5 GENE |
| Dally S. |
- |
CALCIUM PUMPS AND ER STRESS MODULATIONS DURING THROMBOPOIESIS |
| Dalsgaard Nielsen J. |
- |
COMPARISON OF INTERNATIONAL NORMALIZED RATIOS (INRS) DETERMINED BY INRATIO AND COAGU-CHEK XS WITH PLASMA-BASED LABORATORY INR: INFLUENCE OF LUPUS ANTICOAGULANTS |
| Dalton C.F. |
- |
CHARACTERISATION OF ASE-LIKE ELEMENTS IN THE HUMAN PROTEIN Z GENE PROMOTER |
| Daly M.E. |
- |
CHARACTERISATION OF THE MOLECULAR GENETIC DEFECTS UNDERLYING GLANZMANN'S THROMBASTHENIA IN JORDANIAN FAMILIES |
| |
- |
CHARACTERISATION OF PREDICTED OESTROGEN RESPONSE ELEMENTS IN THE ITGA2 GENE PROMOTER |
| |
- |
FUNCTIONAL CHARACTERISATION OF HAPLOTYPIC VARIATION IN THE GP6 GENE PROMOTER |
| Damås J.K. |
- |
ELEVATED SERUM LEVELS OF LIGHT IN PULMONARY ARTERIAL HYPERTENSION-POTENTIAL INVOLVEMENT IN THROMBUS FORMATION |
| D'Ambrosio R. |
- |
A NEW MUTATION WITHIN PROTEIN Z GENE IS ASSOCIATED WITH VERY LOW PROTEIN LEVELS IN WOMEN WITH FETAL LOSS |
| D'Ambrosio R.R.D. |
- |
A B3 ASP217VAL SUBSTITUTION IN A PATIENT WITH VARIANT GLANZMANN THROMBATHENIA SEVERELY AFFECTS INTEGRIN AIIBB3 FUNCTIONS |
| Damiano B.P. |
- |
EFFECTS OF JNJ-28045446 ON P2Y12 ADP RECEPTOR FUNCTION IN VITRO AND IN VIVO |
| D'Amico E.A. |
- |
NEONATAL THROMBOSIS: A SERIES OF 18 CASES FROM A BRAZILIAN PEDIATRIC CENTER |
| |
- |
ACUTE THROMBOSIS IN A PATIENT WITH ACQUIRED FVIII INHIBITOR: CASE REPORT |
| |
- |
MUNCHAUSEN SYNDROME X COAGULOPATHIES |
| |
- |
THROMBOSIS IN PRETERM INFANTS: A REPORT OF FIVE CASES TREATED WITH HIGH DOSE OF TISSUE PLASMINOGEN ACTIVATOR (R-TPA) |
| |
- |
DIFFICULTIES IN THE TREATMENT OF REFRACTORY IMMUNE THROMBOCYTOPENIC PURPURA WITH BLEEDING SYMPTOMS |
| Daminato R. |
- |
SAFETY AND EFFICACY OF NADROPARIN FOR THE MANAGEMENT OF VENOUS THROMBOEMBOLISM OR THROMBOPHILIA IN PREGNANCY |
| |
- |
PROTHROMBOTIC FACTORS AND OXIDATIVE STRESS MARKERS IN A TYPE 2 DIABETES POPULATION |
| Damme A.V. |
- |
EVALUATION OF THROMBOLYTIC THERAPY WITH TISSUE-TYPE PLASMINOGEN ACTIVATOR (T-PA) FOR PROSTHETIC VALVE THROMBOSIS IN CHILDREN: A SINGLE INSTITUTION EXPERIENCE |
| Danchev D. |
- |
EVALUATION OF THE BEHAVIOR OF (QUATERNIZED) POLY[(2-DIMETHYLAMINO)ETHYL METHACRYLATE] AND (CROSSLINKED) N-CARBOXYETHYLCHITOSAN AND THEIR COMPLEXES IN CONTACT WITH BLOOD |
| Dandekar T. |
- |
ANALYSIS OF THE INTERACTOME IN HUMAN PLATELETS |
| D'Andrea G. |
- |
A B3 ASP217VAL SUBSTITUTION IN A PATIENT WITH VARIANT GLANZMANN THROMBATHENIA SEVERELY AFFECTS INTEGRIN AIIBB3 FUNCTIONS |
| Danesh J. |
- |
COMPARISON OF THE ASSOCIATIONS BETWEEN HAEMOSTATIC AND INFLAMMATORY VARIABLES AND CHD RISK: FLETCHER CHALLENGE STUDY |
| Dangas G. |
- |
MAJOR BLEEDING IN ACUTE CORONARY SYNDROME PATIENTS IS ASSOCIATED WITH A MAKED PRO-INFLAMMATORY RESPONSE: RESULTS FROM THE ACUITY INFLAMMATORY BIOMARKER SUB-STUDY |
| Dangelmaier C.A. |
- |
CBL-B: A PHYSIOLOGICALLY IMPORTANT SIGNALING MOLECULE FOR COLLAGEN-DEPENDENT ACTIVATION |
| D'Angelo A. |
- |
PATIENTS WITH LUPUS ANTICOAGULANTS AND HISTORY OF THROMBOSIS CARRY ANTIBODIES TO BETA2-GLYCOPROTEIN I INHIBITING THE PHOSPHOLIPID OXIDATION-DEPENDENT ACTIVITY OF APC |
| Daniel J.L. |
- |
CBL-B: A PHYSIOLOGICALLY IMPORTANT SIGNALING MOLECULE FOR COLLAGEN-DEPENDENT ACTIVATION |
| Daniel J.M. |
- |
DOUBLE STRANDED RNA-MEDIATED MODULATION OF THE BALANCE BETWEEN TISSUE FACTOR AND THROMBOMODULIN ON THE ENDOTHELIUM: RELEVANCE FOR DYSFUNCTIONAL HAEMOSTASIS IN VIRAL INFECTIONS |
| |
- |
THE UROKINASE SYSTEM REGULATES THE MOBILIZATION, HOMING AND DIFFERENTIATION OF PROGENITOR CELLS INTO ENDOTHELIAL CELLS |
| Daniel J. |
- |
FACTOR VII ACTIVATING PROTEASE INHIBITS THE UROKINASE PLASMINOGEN ACTIVATION SYSTEM AND STIMULATES GELATINASES (MATRIX METALLOPROTEINASES-2 AND -9) IN VASCULAR SMOOTH MUSCLE AND ENDOTHELIAL CELLS |
| Daniels T.M. |
- |
VON WILLEBRAND FACTOR (VWF) MULTIMER ANALYSIS BY IN-GEL IMMUNOSTAINING AND INFRARED IMAGING |
| Danielson J. |
- |
FIBRINOGEN HAPLOTYPES AND PLASMA LEVELS SHOW INDEPENDENT ASSOCIATION TO ISCHEMIC STROKE |
| Dann E.J. |
- |
ADAMTS-13 ACTIVITY, ANTIGEN AND INHIBITOR ANTIBODIES IN TTP PATIENTS A SINGLE CENTER EXPERIENCE |
| Danoff T.M. |
- |
A PHASE II DOUBLE-BLIND PLACEBO-CONTROLLED PARALLEL-GROUP RANDOMIZED STUDY OF EXTENDED PROPHYLAXIS WITH ODIPARCIL FOLLOWING TOTAL HIP ARTHROPLASTY (THA) |
| d'Apice A. |
- |
INCREASED CD39 EXPRESSION PROTECTS KIDNEYS FROM ISCHEMIA REPERFUSION INJURY VIA A REDUCTION IN INFILTRATING CD4+T CELLS: PROTECTION IS AFFORDED BY BOTH EXPRESSIONS ON EITHER TISSUE OR ON CELLULAR BLOOD |
| |
- |
MICE TRANSGENIC FOR THROMBOMODULIN EXHIBIT PROTECTION FROM VENOUS THROMBOSIS |
| Dardik R. |
- |
ALPHA V SUPPRESSION BY SIRNA AUGMENTS OR INHIBITS VEGF AND VEGFR-2 EXPRESSION DEPENDING ON THE ORIGIN OF ENDOTHELIAL CELLS |
| Dargaud Y. |
- |
THROMBIN GENERATION TEST IN THE MONITORING OF PROTHROMBIN COMPLEX CONCENTRATES |
| |
- |
NEUTRALIZING ANTI-FVIII ANTIBODIES HAVE A DIFFERENT IMPACT IN INHIBITING THROMBIN GENERATION |
| |
- |
MONITORING OF RECOMBINANT FVIIA BY THROMBIN GENERATION TEST |
| |
- |
THROMBIN GENERATING CAPACITY IS HIGHLY DECREASED AND DELAYED IN PATIENTS WITH VON WILLEBRAND DISEASE |
| Darghouth D. |
- |
HETEROGENEITY OF ESSENTIAL THROMBOCYTHEMIA: VARIABLE EXPRESSION OF THE V617F JAK2 MUTATION AND THE PLATELET CD36 LEVEL. NO ASSOCIATION WITH THROMBOTIC MANIFESTATIONS |
| D'Armini A.M. |
- |
LONG TERM RESULTS OF PULMONARY ENDARTERECTOMY (PEA) IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH). THE PAVIA ENDARTERECTOMY PROGRAM |
| |
- |
EFFICACY OF FONDAPARINUX IN HEPARIN-INDUCED THROMBOCYTOPENIA WITH OR WITHOUT THROMBOEMBOLIC COMPLICATIONS |
| Darmon P. |
- |
SHORT-TERM OPTIMIZATION OF GLYCEMIC CONTROL WITH INTENSIVE INSULIN THERAPY DECREASE CIRCULATING PLATELET AND ENDOTHELIAL MICROPARTICLES LEVELS IN TYPE 2 DIABETIC PATIENTS |
| Darnige L. |
- |
PLATELET MICROPARTICLES LEVELS AND PREVALENCE OF ANTIPROTHROMBIN AND ANTI-BETA-2-GLYCOPROTEIN I ANTIBODIES IN THROMBOANGIITIS OBLITERANS (BUERGER'S DISEASE) |
| D'Arpa S. |
- |
THE HYPERCOAGULABILITY AND VASCULAR ENDOTHELIUM ABNORMAL CYTOKINES' RELEASE MAY INFLUENCE THE PROGRESSION OF THE OSTEOPATHY IN HOMOZYGOUS B-THALASSEMIA PATIENTS |
| Dart A. |
- |
ENDOTHELIAL CELL TYPE AND ACTIVATION STATE AFFECTS SOLUBLE P-SELECTIN MEDIATED LEUKOCYTE ADHESION |
| Darvishi S. |
- |
HUMAN MALIGNANT CELLS EXPRESS FUNCTIONALLY ACTIVE ENDOTHELIAL PROTEIN C RECEPTOR |
| Das R. |
- |
INVESTIGATION OF THROMBOPHILIA DURING PREGNANCY AND PUERPERIUM: A STUDY FROM NORTH INDIA |
| Dasgupta S. |
- |
COMPARISON OF THE IMMUNOGENICITY OF DIFFERENT THERAPEUTIC PREPARATIONS OF HUMAN FACTOR VIII IN THE MURINE MODEL OF HEMOPHILIA A |
| |
- |
VWF INHIBITS OF THE ENDOCYTOSIS OF FACTOR VIII BY MURINE BONE MARROW-DERIVED DENDRITIC CELLS |
| |
- |
IDENFICATION OF THE RECEPTORS IMPLICATED IN THE ENDOCYTOSIS OF FACTOR VIII BY HUMAN DENDRITIC CELLS |
| |
- |
EXPOSED MANNOSYLATION ON THERAPEUTIC FACTOR VIII MEDIATES ITS ENDOCYTOSIS BY HUMAN DENDRITIC CELLS LEADING TO ACTIVATION OF CD4+ T LYMPHOCYTES |
| Dash C.H. |
- |
CONTINUOUS INFUSION OF A HIGH PURITY FACTOR IX (HPFIX) CONCENTRATE IN SURGERY |
| |
- |
CLINICAL EXPERIENCE WITH A FACTOR XI (FXI) CONCENTRATE |
| |
- |
CLINICAL EXPERIENCE WITH A HIGH PURITY FACTOR IX CONCENTRATE IN YOUNG CHILDREN |
| |
- |
USE OF A HIGH PURITY FACTOR IX (FIX) CONCENTRATE IN SURGERY |
| Dashevsky O. |
- |
THE ROLE OF PLATELET MICROPARTICLES IN ANGIOGENESIS AND TUMOR BIOLOGY |
| Dasi M. |
- |
EARLY TISSUE FACTOR-INDUCED THROMBIN GENERATION IN PLATELETS: INFLUENCE OF ASPIRIN AND ASPIRIN PLUS CLOPIDOGREL |
| Dasi M.A. |
- |
EFFICACY OF FACTOR XIII SUBSTITUTION IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE |
| Dasque E. |
- |
EFFECT OF TWO DOSES OF ORAL OESTROGEN REPLACEMENT THERAPY ON THE PROTEIN C SYSTEM IN POSTMENOPAUSAL WOMEN. A RANDOMISED DOUBLE BLIND PLACEBO-CONTROLLED STUDY |
| D'Atri L.P. |
- |
GALECTIN-1 BINDING TO PLATELETS: A NEW MECHANISM FOR PLATELET ACTIVATION |
| |
- |
ROLE OF PPAR-GAMMA ACTIVATION IN MEGAKARYOCYTOPOIESIS |
| |
- |
IMPAIRED THROMBOPOIESIS AFTER STEM CELL INFECTION WITH JUNIN VIRUS |
| |
- |
DIFFERENTIATION OF CD34+ CELLS MEDIATED BY THROMBOPOIETIN AND MONOCYTES/MACROPHAGES |
| |
- |
EFFECT OF ANTIINFLAMMATORY DRUGS ON HUMAN NEUTROPHILS IN ENDOTHELIAL CELL DAMAGE INDUCED BY SHIGA TOXIN-1 |
| Daubeney P.E.F. |
- |
IS MEAN PLATELET VOLUME A USEFUL MARKER FOR THE 22Q11 DELETION |
| Dauge M. |
- |
SCREENING FOR THROMBOPHILIA IN A RETROSPECTIVE STUDY OF 320 WOMEN WITH PREGNANCY COMPLICATIONS |
| Daurès J.P. |
- |
THE RISK OF UNEXPLAINED FOETAL LOSS IS DOSE-DEPENDENTLY RELATED TO THE EXPRESSION OF THE GLY219 VARIANT OF THE ENTOTHELIAL PROTEIN C RECEPTOR BY THE MOTHER, BY THE FATHER AND BY THE COUPLE |
| |
- |
ASYMPTOMATIC CARRIAGE OF THE JAK2V617F MUTATION IS ASSOCIATED WITH UNEXPLAINED EMBRYONIC AND FOETAL LOSS DURING THE FIRST PREGNANCY |
| Dauzat M. |
- |
ASYMPTOMATIC CARRIAGE OF THE JAK2V617F MUTATION IS ASSOCIATED WITH UNEXPLAINED EMBRYONIC AND FOETAL LOSS DURING THE FIRST PREGNANCY |
| |
- |
THE RISK OF UNEXPLAINED FOETAL LOSS IS DOSE-DEPENDENTLY RELATED TO THE EXPRESSION OF THE GLY219 VARIANT OF THE ENTOTHELIAL PROTEIN C RECEPTOR BY THE MOTHER, BY THE FATHER AND BY THE COUPLE |
| Dávalos L. |
- |
NORMAL RANGE STUDY OF TOTAL HOMOCYSTEINE IN CITRATED AND EDTA PLASMA SAMPLES WITH A NEW TURBIDIMETRIC ASSAY ADAPTED TO AUTOMATED COAGULATION ANALYSERS |
| Davenport J.J. |
- |
ANTITHROMBOTIC THERAPY IN INFANTS WITH SVC SYNDROME: ADDITIONAL MODALITIES ARE REQUIRED |
| Davì G. |
- |
OXIDATIVE STRESS AND PLATELET ACTIVATION IN SUBJECTS WITH MODERATE HYPERHOMOCYSTEINEMIA DUE TO MTHFR 677 C-T POLYMORPHISM |
| |
- |
DETERMINANTS OF PLATELET ACTIVATION IN HEART FAILURE |
| |
- |
ASSOCIATION BETWEEN ENHANCED SOLUBLE CD40 LIGAND AND PLATELET ACTIVATION IN HYPERTENSIVES WITH MICROALBUMINURIA |
| |
- |
ASSOCIATION BETWEEN ENHANCED VEGF LEVELS AND PLATELET ACTIVATION IN HYPERTENSIVE PATIENTS |
| David J.L. |
- |
THROMBIN ACTIVITY PROFILE: A POWERFUL EX VIVO SCREENING TEST FOR THE DEVELOPMENT OF ANTICOAGULANT DRUGS |
| David M. |
- |
NEONATAL RENAL VEIN THROMBOSIS - 15 YEARS OF LITERATURE |
| David-Dufilho M. |
- |
THE THROMBIN ENDOTHELIAL RECEPTORS, THROMBOMODULIN AND PAR-1, ACTIVATE EGF RECEPTOR THROUGH DISTINCT SIGNALLING |
| |
- |
THIOSULFINATES MODULATE PLATELET ACTIVATION AND MONOCYTE FUNCTION BY REACTION WITH SURFACE FREE SULFHYDRYLS AND INTERNAL THIOL-CONTAINING PROTEINS |
| Davidson S.J. |
- |
DO PATIENTS WITH HEPARIN INDUCED THROMBOCYTOPENIA HAVE ANTIBODIES TO ADAMTS-13 |
| Davidson B.L. |
- |
EVALUATION OF THE FACTOR XA (FXA) INHIBITOR, PRT054021 (PRT021), AGAINST ENOXAPARIN IN A RANDOMIZED TRIAL FOR THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER TOTAL KNEE REPLACEMENT (EXPERT) |
| Davidson S.J. |
- |
IS MEAN PLATELET VOLUME A USEFUL MARKER FOR THE 22Q11 DELETION |
| |
- |
TWO PATIENTS WITH TYPE III PROTEIN S DEFICIENCY WHO UNDERWENT CARDIAC SURGERY WITH CARDIOPULMONARY BYPASS |
| Davidson B.L. |
- |
DABIGATRAN ETEXILATE VERSUS ENOXAPARIN IN PREVENTING VENOUS THROMBOEMBOLISM FOLLOWING TOTAL KNEE ARTHROPLASTY |
| Davie E.W. |
- |
FUNCTIONAL CHARACTERIZATION OF PROLINE-RICH GLA PROTEINS (PRGPS) 1 AND 2 |
| Davies S. |
- |
INCREASED AGE RELATED EXPRESSION OF FVIII IN TWO UNRELATED FEMALES WITH SEVERE HEMOPHILIA A AND NONRANDOM X-INACTIVATION |
| Davila M. |
- |
IMPACT OF TISSUE FACTOR-BEARING MICROPARTICLES DERIVED FROM TUMOR CELLS ON COAGULATION ACTIVATION |
| |
- |
THERAPEUTIC ANTIBODIES AGAINST CD40 LIGAND, TNF-ALPHA AND VEGF SHARE MECHANISTIC FEATURES IN COMMON WITH PLATELET ACTIVATING ANTIBODIES IN HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) |
| Davis S.M. |
- |
LATE BREAKING CLINICAL TRIAL: RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER PHASE III STUDY TO ASSESS RFVIIA EFFICACY IN ACUTE INTRACEREBRAL HEMORRHAGE: THE FAST TRIAL |
| Davis G. |
- |
PREVENTION OF VENOUS THROMBOEMBOLISM VIA PARTIAL FACTOR IXA INHIBITION |
| |
- |
LACK OF EFFECT ON MARKERS OF THROMBIN GENERATION AND FIBRINOLYSIS BY PARTIAL FACTOR IXA INHIBITION FOLLOWING HIP FRACTURE SURGERY |
| Davis D. |
- |
THROMBOPROPHYLAXIS IN HIGH-RISK ADOLESCENT INPATIENTS |
| Dawkins R. |
- |
THE PRIORITY TRIAL: PLASMIN REVASCULARIZATION OF ACUTE LOWER EXTREMITY NATIVE ARTERY OR BYPASS GRAFT OCCLUSIONPHASE I/II PROTOCOL DESIGN |
| Dawood B.B. |
- |
REDIAGNOSIS OF PLATELET "SECRETION" DISORDERS BY SIMULTANEOUS MEASUREMENT OF AGGREGATION AND ATP SECRETION |
| Daxecker H. |
- |
A TAILOR-MADE PEPTIDE-AFFINITY COLUMN TO IDENTIFY NOVEL BINDING PARTNERS FOR A CYTOPLASMIC MOTIF OF THE PLATELET INTEGRIN ALPHA IIB |
| Day Y.J. |
- |
SIRTINOL INHIBITS HUMAN PLATELETS AGGREGATION AND Ca2+ RELEASE |
| Day A.J. |
- |
ANTICOAGULANT HEPARAN SULFATES MODULATE TISSUE REMODELING AT OVULATION |
| Day Y. |
- |
THE NEGATIVE EFFECT OF LEVOBUPIVACAINE ON COLLAGEN-INDUCED PLATELET AGGREGATION |
| Dazzi F. |
- |
ATTEMPTED ERADICATION OF HIGH RESPONDING FVIII INHIBITOR BY ALLOGENEIC BONE MARROW TRANSPLANTATION |
| de Agostini A.I. |
- |
ANTICOAGULANT HEPARAN SULFATES MODULATE TISSUE REMODELING AT OVULATION |
| De Amici M. |
- |
EFFICACY OF FONDAPARINUX IN HEPARIN-INDUCED THROMBOCYTOPENIA WITH OR WITHOUT THROMBOEMBOLIC COMPLICATIONS |
| De Angelis V. |
- |
ANTIPHOSPHOLIPID ANTIBODIES AND EX-VIVO ENDOTHELIAL PERTURBATION |
| De Angelis M. |
- |
RAPID INCREASE OF EXPRESSION OF INDUCIBLE CYCLOOXYGENASE (COX-2) IN MONOCYTES OF PATIENTS WITH TYPE II DIABETES MELLITUS (T2DM) EXPOSED IN VIVO TO HYPERGLYCEMIC SPIKES |
| de Bastos M. |
- |
MANAGING SUSPECTED VENOUS THROMBOEMBOLISM IN A MIXED PRIMARY AND SECONDARY CARE SETTING USING STANDARD CLINICAL ASSESSMENT AND D-DIMER IN A NON-INVASIVE DIAGNOSTIC STRATEGY |
| de Bastos M.R.D. |
- |
MANAGING SUSPECTED VENOUS THROMBOEMBOLISM IN A MIXED PRIMARY AND SECONDARY CARE SETTING USING STANDARD CLINICAL ASSESSMENT AND D-DIMER IN A NON-INVASIVE DIAGNOSTIC STRATEGY |
| de Bastos M. |
- |
DURATION OF SYMPTOMS AND D-DIMER TESTING FOR VENOUS THROMBOEMBOLISM RULING-OUT |
| de Bastos M.R.D. |
- |
DURATION OF SYMPTOMS AND D-DIMER TESTING FOR VENOUS THROMBOEMBOLISM RULING-OUT |
| De Berardis G. |
- |
PERSISTENT PLATELET ACTIVATION IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH LOW DOSES OF ASPIRIN |
| De Biasi E. |
- |
PRENATAL DIAGNOSIS OF HAEMOPHILIA A BY USING INTRON 1 INVERSION MUTATION |
| de Bortoli N. |
- |
WHOLE-BLOOD CLOTTING FOR EVALUATING THROMBIN GENERATION IN CHRONIC LIVER FAILURE |
| de Bosch N. |
- |
USE OF RFVIIA IN ELECTIVE SURGERY IN CASES WITH CONGENITAL COAGULOPATHIES AND INHIBITORS |
| de Bruijne E.L.E. |
- |
ADAMTS13 LEVELS ARE ASSOCIATED WITH THE RISK OF ARTERIAL THROMBOSIS IN YOUNG SUBJECTS |
| de Bruin T.W.A. |
- |
MARKERS OF FIBRINOLYSIS ARE INDEPENDENTLY RELATED TO FATTY LIVER AND HYPERTRIGLYCERIDEMIA IN FAMILIAL COMBINED HYPERLIPIDEMIA; EVIDENCE FOR INVOLVEMENT OF APOLIPOPROTEIN E |
| De Candia E. |
- |
NON-PAR THROMBIN RECEPTORS |
| |
- |
SURGICAL BLEEDING AFTER PREOPERATIVE UNFRACTIONATED HEPARIN AND LOW MOLECULAR WEIGHT HEPARIN AT CORONARY BYPASS SURGERY |
| |
- |
MUTATED POSITION OF NMHC-A PREDICTS THE NATURAL HISTORY OF MYH9-RELATED DISEASE |
| |
- |
MARKED EMPERIPOLESIS AND INCREASED P-SELECTIN EXPRESSION ON MEGAKARYOCYTES IN A NOVEL CASE OF GRAY PLATELET SYNDROME |
| De Caterina R. |
- |
THE PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR(PPAR)GAMMA AGONIST ROSIGLITAZONE (RSG) INHIBITS CYCLOOXYGENASE(COX)-2 EXPRESSION BY SUPPRESSING PKCAPLHA AND CREB ACTIVATION |
| |
- |
HYDROXYTYROSOL, THE MAJOR OLIVE OIL PHENOLIC ANTIOXIDANT, REGULATES EXPRESSION AND ACTIVITY OF MATRIX METALLOPROTEINASE(MMP)-9 IN HUMAN MONOCYTOID CELLS - POSSIBLE CONTRIBUTION TO PLAQUE STABILITY |
| |
- |
SURGICAL BLEEDING AFTER PREOPERATIVE UNFRACTIONATED HEPARIN AND LOW MOLECULAR WEIGHT HEPARIN AT CORONARY BYPASS SURGERY |
| |
- |
HIGH GLUCOSE INHIBITS NITRIC OXIDE PRODUCTION THROUGH AN HYPEROSMOLAR EFFECT, WITHOUT INDUCING ENDOTHELIAL CELL ADHESION SURFACE EXPRESSION IN HUMAN ENDOTHELIAL CELLS |
| |
- |
HIGH INSULIN IMPAIRS PI-3 KINASE/AKT-MEDIATED INSULIN SIGNALING IN HUMAN ENDOTHELIAL CELLS: AN IN VITRO INDUCTION OF INSULIN RESISTANCE? |
| |
- |
PROSTACYCLIN IMPROVES TRANSCORONARY MYOCARDIAL DELIVERY OF ADIPOSE TISSUE-DERIVED STROMAL CELLS |
| |
- |
INHIBITORY EFFECT OF COFFEE ON PLATELET AGGREGATION |
| |
- |
HOMOCYSTEINE INDUCES VCAM-1 GENE EXPRESSION THROUGH NF-KB AND NAD(P)H OXIDASE ACTIVATION: PROTECTIVE ROLE OF MEDITERRANEAN DIET POLYPHENOLIC ANTIOXIDANTS |
| |
- |
THE OMEGA-3 FATTY ACID DOCOSAHEXAENOATE (DHA) REDUCES CYCLOOXYGENASE(COX)-2 INDUCTION BY INHIBITING NADP(H) OXIDASE AND PKC: POSSIBLE INVOLVEMENT OF 15-LIPOXIGENASE(LO)-1 |
| de Cos C. |
- |
CLINICAL, GENETIC, FUNCTIONAL AND CONFORMATIONAL HETEROGENEITY OF CONGENITAL ANTITHROMBIN DEFICIENCY. RESULTS FROM 27 UNRELATED CASES |
| De Cristofaro R. |
- |
NON-PAR THROMBIN RECEPTORS |
| |
- |
EFFECT OF PH AND TEMPERATURE ON ADAMTS-13 CATALYSIS |
| |
- |
THROMBIN-MEDIATED IMPAIRMENT OF FGF-2 ACTIVITY |
| |
- |
KINETICS STUDIES OF A NATURALLY OCCURRING MUTATION ON FACTOR X (FX) GENE (G222D) |
| |
- |
MECHANISMS OF INHIBITION OF THROMBIN-INDUCED PLATELET ACTIVATION BY FIBRINOGEN GAMMA'(408-427) PEPTIDE |
| De Curtis A. |
- |
ASSOCIATION OF C-REACTIVE PROTEIN, OBESITY AND METABOLIC SYNDROME IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION |
| |
- |
FIBRIN D-DIMERS IS ASSOCIATED WITH PREVALENT CARDIOVASCULAR EVENTS IN THE MOLI-SANI STUDY |
| |
- |
ASSOCIATION OF C-REACTIVE PROTEIN AND ALCOHOL INTAKE IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION |
| |
- |
ASSOCIATION OF C-REACTIVE PROTEIN AND WHITE BLOOD CELL COUNT WITH PHYSICAL ACTIVITY IN HEALTHY SUBJECTS |
| De Deyn P.P. |
- |
GENERATION OF CARBOXYPEPTIDASE U (TAFIA) IN ISCHEMIC STROKE PATIENTS RECEIVING THROMBOLYTIC THERAPY |
| De Fanti A. |
- |
A SUCCESSFUL IMMUNOMODULATION-ITI RESCUE IN SEVERE HAEMOPHILIA A WITH HIGH RESPONDER INHIBITOR |
| De Feudis L. |
- |
DETERMINANTS OF PLATELET ACTIVATION IN HEART FAILURE |
| De Filippis V. |
- |
THE Na+-BOUND AND Na+-FREE CONFORMATION OF THROMBIN PROBED BY SOLUTION STUDIES |
| de Gaetano G. |
- |
RESPONSE VARIABILITY TO ASPIRIN AS ASSESSED BY A PLATELET FUNCTION-ANALYZING DEVICE IN 5,007 SUBJECTS: A SYSTEMATIC REVIEW OF 40 STUDIES |
| de Gaetano M. |
- |
INTERLEUKIN-1B GENE HAPLOTYPES AND INFLAMMATORY/PROCOAGULANT RESPONSE OF HUMAN MONONUCLEAR CELLS |
| de Gaetano G. |
- |
ASSOCIATION OF C-REACTIVE PROTEIN, OBESITY AND METABOLIC SYNDROME IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION |
| |
- |
FIBRIN D-DIMERS IS ASSOCIATED WITH PREVALENT CARDIOVASCULAR EVENTS IN THE MOLI-SANI STUDY |
| |
- |
GALLIC ACID BLUNTS PLATELET INHIBITION BY ASPIRIN AND OTHER POLYPHENOLS: IMPLICATIONS FOR THE ANTITHROMBOTIC PROPERTIES OF ASPIRIN AND DIETARY POLYPHENOLS |
| |
- |
PLATELET BUT NOT LEUKOCYTE ACTIVATION IS A PREREQUISITE FOR PLATELET-LEUKOCYTE INTERACTION IN HUMAN WHOLE BLOOD |
| |
- |
DETERMINANTS OF PLATELET AGGREGATE FORMATION WITH EITHER POLYMORPHONUCLEAR LEUKOCYTES OR MONOCYTES IN HUMAN WHOLE BLOOD |
| |
- |
TISSUE FACTOR GENE TAG-SNPS AND HAPLOTYPES AND THE RISK OF MYOCARDIAL INFARCTION |
| |
- |
LEPTIN INDUCES TISSUE FACTOR EXPRESSION IN HUMAN MONOCYTES |
| De Gaetano G. |
- |
THROMBOCYTOPENIA AND CONGENITAL RADIAL DYSPLASIA: A CONTINUUM SPECTRUM OF DISEASES. CASE REPORT |
| de Gaetano G. |
- |
ASSOCIATION OF C-REACTIVE PROTEIN AND WHITE BLOOD CELL COUNT WITH PHYSICAL ACTIVITY IN HEALTHY SUBJECTS |
| |
- |
ASSOCIATION OF C-REACTIVE PROTEIN AND ALCOHOL INTAKE IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION |
| |
- |
DIFFERENTIAL ANALYSIS BY 2-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS (2D-DIGE) OF HUMAN PLATELET PROTEINS RELEASED FOLLOWING THROMBIN ACTIVATION: IDENTIFICATION OF LAMIN A, A NOVEL PLATELET PROTEIN |
| de Graeff P.A. |
- |
LOW ABSOLUTE RISK OF VENOUS THROMBOEMBOLISM (VTE) ASSOCIATED WITH ORAL CONTRACEPTIVES IN WOMEN WITH INCREASED LEVELS OF FVIII:C. A RETROSPECTIVE FAMILY COHORT STUDY |
| |
- |
LOW ABSOLUTE RISK OF VENOUS THROMBOEMBOLISM (VTE) ASSOCIATED WITH ORAL CONTRACEPTIVES IN WOMEN WITH PROTHROMBIN 20210A. A RETROSPECTIVE FAMILY COHORT STUDY |
| De Gregorio A.M. |
- |
LOW INSULIN-LIKE GROWTH FACTOR (IGF) I, IGF BINDING PROTEIN-3 AND ACID LABILE SUBUNIT (ALS) LEVELS IN YOUNG ISCHEMIC STROKE: A PROSPECTIVE CASE-CONTROL STUDY |
| de Groot P.G. |
- |
PHENOTYPE HETEROGENEITY IN SEVERE HAEMOPHILIA |
| |
- |
NOVEL MOLECULAR DEFECT IN THE PLATELET ADP RECEPTOR P2Y12 OF A PATIENT WITH HAEMORRHAGIC DIATHESIS |
| de Groot R. |
- |
ADAMTS13 AND VWF IN PEDIATRIC PATIENTS WITH SEVERE MENINGOCOCCAL SEPSIS |
| de Groot P.G. |
- |
SYNERGISTIC EFFECTS OF HYPOFIBRINOLYSIS AND GENETIC AND ACQUIRED RISK FACTORS IN VENOUS THROMBOSIS |
| |
- |
HYPOFIBRINOLYSIS AS A RISK FACTOR FOR MYOCARDIAL INFARCTION IN MEN |
| |
- |
THE OUTER-SURFACES OF SCHISTOSOMA MANSONI DURING THE LIFE-CYCLE DEMONSTRATE DIFFERENTIAL PROPERTIES TOWARDS PLATELET ADHESION |
| |
- |
WASHOUT PERIOD AND FVIII:C IN PATIENTS WITH SEVERE HEMOPHILIA A |
| De Groot P.G. |
- |
GPVI IN THE PLASMA OF HEALTHY INDIVIDUALS AND PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP), MEASURED BY A NOVEL ENZYME-LINKED IMMUNOSORBANT ASSAY |
| de Groot P. |
- |
ANTIPHOSPHOLIPID ANTIBODIES DISTURB 2D LATTICE FORMATION OF ANNEXINE A5 ON ACTIVATED PLATELETS |
| de Groot P.G. |
- |
PSGL1 AND LDL-RECEPTORS MEDIATE ADHESION OF LEUKOCYTES TO BETA2-GLYCOPROTEIN-I |
| |
- |
LIVER AND SPLEEN MACROPHAGES CONTRIBUTE TO THE CLEARANCE OF VON WILLEBRAND FACTOR AND ITS COMPLEX WITH FACTOR VIII |
| De Groot E. |
- |
EVIDENCE FOR A HIGH AFFINITY ADAMTS13 BINDING SITE DISTAL TO THE VWF A DOMAINS |
| de Groot P.G. |
- |
ACTIVE CONFORMATION OF VON WILLEBRAND FACTOR IN TTP IS NOT RESTRICTED TO ULTRA-LARGE MULTIMERS |
| de Groot R. |
- |
NON-CONSERVED/VARIABLE REGIONS IN THE ADAMTS13 METALLOPROTEINASE DOMAIN ARE DETERMINANTS OF SUBSTRATE SPECIFICITY |
| de Groot P.G. |
- |
GLYCOPROTEIN IB-ALPHA CONTRIBUTES TO TISSUE FACTOR-INDEPENDENT THROMBIN GENERATION BY RECOMBINANT FACTOR VIIA ON THE ACTIVATED PLATELET SURFACE |
| |
- |
ACTIVATION OF PLATELETS BY DIMERIC 2-GLYCOPROTEIN I REQUIRES SIGNALING VIA BOTH GLYCOPROTEIN IBalpha AND APOLIPOPROTEIN E RECEPTOR 2' |
| |
- |
DIMERIC 2-GPI BINDS TO LDL-BINDING DOMAIN 1 OF APOER2. PLATELETS EXPRESS THREE 3 DIFFERENT SPLICE VARIANTS OF APOER2 OF WHICH APOER24-5 IS THE MOST ABUNDANT |
| De Guzman C. |
- |
ANAMNESIS IN PATIENTS WITH HEMOPHILIA AND INHIBITORS WHO RECEIVE ACTIVATED PROTHROMBIN COMPLEX CONCENTRATES FOR PROPHYLAXIS |
| de Haan J. |
- |
COMPARISON OF A NEW CARTRIDGE* FOR THE PFA-100 WITH OTHER PLATELET FUNCTION ASSAYS FOR MEASURING THE EFFECT OF CLOPIDOGREL THERAPY IN CARDIOVASCULAR PATIENTS |
| de Jonghe B. |
- |
FIBRIN MONOMER BY A QUANTITATIVE ASSAY IN PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION |
| de Kruif M.D. |
- |
ENHANCED THROMBUS FORMATION AFTER CHRONIC CHLAMYDIA PNEUMONIAE INFECTION IN A MURINE CAROTID ARTERY THROMBOSIS MODEL |
| de la Corte-Rodriguez H. |
- |
RADIOSYNOVIORTHESIS IS NECESSARY IN HEMOPHILIC PATIENTS DESPITE PROHYLAXIS |
| |
- |
SURGERY IN HEMOPHILIA PATIENTS WITH INHIBITORS: REPORT OF 91 SURGICAL PROCEDURES |
| de la Peña A. |
- |
EFFECT OF PROLAME, A 17 BETA-AMINOESTROGEN DERIVATIVE, ON CELL HEMOSTASIS |
| |
- |
BISBUDIAME, AN ESTROGEN DERIVATIVE WITH AN ANTITHROMBOTIC EFFECT |
| de la Red G. |
- |
THROMBIN GENERATION IN BEHET'S DISEASE: RELATIONSHIP WITH THROMBOSIS |
| de Laaf L. |
- |
THE IMPORTANCE OF DETECTING ANTI-ADAMTS-13 ANTIBODIES IN PATIENTS WITH SEVERE ADAMTS-13 DEFICIENCY |
| de Laat B. |
- |
THE IMPORTANCE OF DETECTING ANTI-ADAMTS-13 ANTIBODIES IN PATIENTS WITH SEVERE ADAMTS-13 DEFICIENCY |
| |
- |
CORRELATION BETWEEN THE POTENCY OF A BETA2-GLYCOPROTEIN I DEPENDENT LUPUS ANTICOAGULANT AND THE LEVEL OF RESISTANCE TO ACTIVATED PROTEIN C |
| de Larrañaga G.F. |
- |
THROMBOPHILIA IN HIV-INFECTED PATIENTS WITH OSTEONECROSIS: IS THERE A REAL CONNECTION? THE FIRST CASE-CONTROL STUDY |
| de Larrañaga G. |
- |
EFFECTS OF ANTI-BETA2-GLYCOPROTEIN I ANTIBODIES FROM APL PATIENTS WITH APS OR WITH LEPROSY IN AN IN VIVO MODEL OF APS |
| de Leeuw P.W. |
- |
THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) THR325ILE AND FACTOR XII C46T POLYMORPHISMS IN ATHEROSCLEROTIC RENAL ARTERY STENOSIS |
| De Lorenzo F. |
- |
ACUTE EFFECT OF STATINS ON THE REGULATION AND EXPRESSION OF CANDIDATE GENES (CD36, MMP-9 AND IL-8) IN ATHEROSCLEROSIS IN HIV-INFECTED PATIENTS |
| De Lucia F. |
- |
ASSOCIATION OF C-REACTIVE PROTEIN AND WHITE BLOOD CELL COUNT WITH PHYSICAL ACTIVITY IN HEALTHY SUBJECTS |
| |
- |
ASSOCIATION OF C-REACTIVE PROTEIN AND ALCOHOL INTAKE IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION |
| |
- |
FIBRIN D-DIMERS IS ASSOCIATED WITH PREVALENT CARDIOVASCULAR EVENTS IN THE MOLI-SANI STUDY |
| |
- |
ASSOCIATION OF C-REACTIVE PROTEIN, OBESITY AND METABOLIC SYNDROME IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION |
| de Maat M.P.M. |
- |
PLATELET RECEPTOR P2Y12 HAPLOTYPES PREDICT RESTENOSIS AFTER PERCUTANEOUS CORONARY INTERVENTIONS |
| |
- |
THE FACTOR VII ACTIVATING PROTEASE (FSAP) POLYMORPHISM (G534E) IS ASSOCIATED WITH A DECREASED RISK FOR RESTENOSIS AFTER PERCUTANEOUS CORONARY INTERVENTION |
| |
- |
ADAMTS13 LEVELS ARE ASSOCIATED WITH THE RISK OF ARTERIAL THROMBOSIS IN YOUNG SUBJECTS |
| |
- |
ADAMTS13 AND VWF IN PEDIATRIC PATIENTS WITH SEVERE MENINGOCOCCAL SEPSIS |
| |
- |
EFFECTS OF PARTICULATE MATTER AIR POLLUTION ON INFLAMMATION AND HAEMOSTASIS |
| De Maeyer B. |
- |
PARATOPE AND EPITOPE MAPPING OF THE ANTITHROMBOTIC ANTIBODY 6B4 IN COMPLEX WITH PLATELET GLYCOPROTEIN IBALPHA |
| De Maeyer M. |
- |
PARATOPE AND EPITOPE MAPPING OF THE ANTITHROMBOTIC ANTIBODY 6B4 IN COMPLEX WITH PLATELET GLYCOPROTEIN IBALPHA |
| De Maeyer B. |
- |
FUNCTIONAL IN VITRO CHARACTERIZATION OF A NOVEL ADAMTS13 MUTATION (R1095W) AND POLYMORPHISM (S903L) |
| de Maistre E. |
- |
INFLUENCE OF INJECTION SITE ON PROPHYLACTIC DOSE ENOXAPARIN BIOAVAILABILITY IN OBESE PATIENTS |
| De Marco L. |
- |
SPATIO-TEMPORAL CALCIUM SIGNALING ELICITED BY INTEGRIN ALPHA2-BETA1 AND GLICOPROTEIN VI UNDER FLOW |
| |
- |
A NOVEL FLOW CYTOMETRIC METHOD FOR THE DETECTION OF RETICULATED PLATELETS BY AN ANTI-BROMODEOXYURIDINE MONOCLONAL ANTIBODY |
| |
- |
ALTERED BINDING OF PURIFIED TYPE 2M VICENZA VON WILLEBRAND FACTOR TO PLATELET RECEPTOR ALPHAIIBBETA3 AND GPIB-V-IX COMPLEX |
| |
- |
HYPERHOMOCYSTEINEMIA AND THROMBOSIS: THE DIAGNOSTIC ROLE OF POST METHIONINE-LOAD TEST |
| De Mattio M. |
- |
PHENOTYPIC ANALYSIS OF THREE MUTATIONS CAUSING GLANZMANN THROMBASTHENIA |
| de Mazancourt P. |
- |
A NOVEL DYSFIBRINOGENEMIA DETECTED BY ELECTROPHORESIS IN A PATIENT PRESENTING WITH FAMILIAL VENOUS THROMBOEMBOLISM |
| De Meyer S.F. |
- |
THE A/T1381 POLYMORPHISM IN THE A1-DOMAIN OF VON WILLEBRAND FACTOR INFLUENCES THE AFFINITY OF VON WILLEBRAND FACTOR FOR PLATELET GLYCOPROTEIN IB-ALPHA |
| De Meyer S. |
- |
THE VWF-GPIB AXIS AS A THERAPEUTIC TARGET |
| De Meyer S.F. |
- |
RESTORATION OF VON WILLEBRAND FACTOR FUNCTION IN A MURINE MODEL OF SEVERE VON WILLEBRAND DISEASE AFTER LIVER SPECIFIC GENE TRANSFER |
| |
- |
CORONARY ARTERY IN-STENT STENOSIS PERSISTS DESPITE INHIBITION OF THE VON WILLEBRAND FACTOR-COLLAGEN INTERACTION IN BABOONS |
| |
- |
FUNCTIONAL ANALYSIS OF HUMAN PLATELETS IN NOD/SCID MICE |
| de Moerloose P. |
- |
CLINICAL EVALUATION OF A NEW QUANTITATIVE HIGHLY SENSITIVE D-DIMER ASSAY FOR EXCLUSION OF DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM |
| |
- |
INFLUENCE OF CYP2C19 AND CYP3A4 GENE POLYMORPHISMS ON CLOPIDOGREL RESPONSIVENESS IN HEALTHY SUBJECTS |
| De Moerloose P. |
- |
A MULTICENTRE PROSPECTIVE OPEN-LABEL STUDY ASSESSING PHARMACOKINETICS, CLINICAL EFFICACY AND SAFETY OF A TRIPLE-SECURED FIBRINOGEN CONCENTRATE: FIBRINOGENE T-I |
| de Moerloose P. |
- |
DIFFERENCES IN ENDOTHELIAL CELL ACTIVATION BY IGG FROM PATIENTS WITH THE ANTIPHOSPHOLIPID SYNDROME OR WITH IMMUNE THROMBOCYTOPENIC PURPURA |
| De Moerloose P. |
- |
ANTIPHOSPHOLIPID ANTIBODIES AND TLR2 COLOCALIZED IN HUVEC ENDOSOMES |
| de Moerloose P. |
- |
DETECTION OF 23 NOVEL MUTATIONS IN LEBANESE HEMOPHILIA PATIENTS |
| De Moerloose P. |
- |
SEVERE FACTOR XI DEFICIENCY IN A JEWISH CHILD CAUSED BY COMPOUND HETEROZYGOTY FOR A NOVEL NONSENSE MUTATION (TYR-14X, EXON 2) AND THE COMMON TYPE II MUTATION (GLU1 17X, EXON 5).L |
| de MOERLOOSE P. |
- |
A NOVEL P.ASP344VAL SUBSTITUTION IN THE FIBRINOGEN GAMMA-CHAIN CAUSES DYSFIBRINOGENEMIA ASSOCIATED WITH THROMBOSIS |
| de Moerloose P. |
- |
BLEEDING AND THROMBOTIC MANIFESTATION IN 58 PATIENTS WITH CONGENITAL DYSFIBRINOGENEMIA |
| de Mol B.A. |
- |
RETRANSFUSION OF PERICARDIAL BLOOD DOES NOT TRIGGER SYSTEMIC COAGULATION DURING CARDIOPULMONARY BYPASS |
| De Negri F. |
- |
WHOLE-BLOOD CLOTTING FOR EVALUATING THROMBIN GENERATION IN CHRONIC LIVER FAILURE |
| |
- |
BILATERAL THROMBOSIS OF POSTERIOR SHORT CILIORETINAL VESSELS IN A PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME, HYPERHOMOCYSTEINE AND ETEROZIGOUS FOR MTHRF |
| |
- |
BETA-ADRENERGIC RECEPTORS MODULATION OF T-PA RELEASE VIA NO SYNTHASE-DEPENDENT PATHWAY IN NORMOTENSIVE SUBJECTS AND HYPERTENSIVE PATIENTS |
| |
- |
EPINEPHRINE INDUCES LOCAL T-PA RELEASE VIA A NITRIC OXIDE-DEPENDENT PATHWAY IN HUMAN FOREARM |
| de Paula E.V. |
- |
MOLECULAR AND FUNCTIONAL CHARACTERIZATION OF FVIII MUTATIONS IN A FEMALE WITH SEVERE HEMOPHILIA A |
| De Paula E.V. |
- |
DAPSONE TREATMENT IN STEROID-DEPENDENT OR REFRACTORY ADULT ITP PATIENTS CAN AVOID IMMEDIATE SPLENECTOMY AFTER STEROID FAILURE |
| |
- |
DUAL GENE TRANSFER OF FGF-2 AND PDGF-BB USING PLASMID DNA PROMOTES EFFECTIVE ANGIOGENESIS AND ARTERIOGENESIS IN A RODENT MODEL OF HINDLIMB ISCHEMIA |
| |
- |
HEMOSTATIC CHANGES IN BRAZILIAN SPOTTED FEVER |
| de Paula E.V. |
- |
ANALYSIS OF MICROPARTICLES IN DEEP VENOUS THROMBOSIS AND ANTIPHOSPHOLIPID SYNDROME PATIENTS AND CARRIERS OF LEIDEN FACTOR V |
| De Paula E.V. |
- |
SIMULTANEOUS BLEEDING AND THROMBOSIS AS THE INITIAL PRESENTATION OF SUPERWARFARIN POISONING |
| de Prost D. |
- |
COMPONENTS OF VARIABILITY OF D DIMER MEASUREMENT CLOSE TO THE CUT-OFF VALUE |
| de Raucourt E. |
- |
IMMUNE TOLERANCE IN AN ADULT AFTER A LONG TERM HISTORY OF I,HIBITOR |
| de Roos A. |
- |
DIRECT THROMBUS IMAGING WITH MAGNETIC RESONANCE IN THE DISCRIMINATION BETWEEN ACUTE AND CHRONIC DEEP VEIN THROMBOSIS; A PROSPECTIVE PROOF-OF-PRINCIPLE STUDY |
| De Silvestro G. |
- |
THE MANAGEMENT OF HIGH RISK PREGNANT PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME |
| De Simone C. |
- |
LOW INSULIN-LIKE GROWTH FACTOR (IGF) I, IGF BINDING PROTEIN-3 AND ACID LABILE SUBUNIT (ALS) LEVELS IN YOUNG ISCHEMIC STROKE: A PROSPECTIVE CASE-CONTROL STUDY |
| |
- |
RIGHT-TO-LEFT SHUNT, ATRIAL SEPTAL ANEURYSM AND THROMBOPHILIA IN PATIENTS WITH CRYPTOGENIC STROKE OR TIA VERSUS THOSE WITH VENOUS THROMBOEMBOLISM |
| |
- |
DESMOPRESSIN IN PATIENTS WITH CONGENITAL DISORDERS OF PRIMARY HAEMOSTASIS: FOUR YEAR PROSPECTIVE EVALUATION |
| De Smedt E. |
- |
THE NECESSITY OF CONTINUOUS INDIVIDUAL CALIBRATION IN CONTINUOUS FLUOROGENIC MEASUREMENT OF THE THROMBIN GENERATION CURVE |
| De Stasio G. |
- |
PROTHROMBOTIC FACTORS IN INFANTS WITH NEONATAL CEREBRAL INFARCTION |
| De Stefano V. |
- |
A SURVEY ON POST-SURGERY OUTCOMES IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA IN A RETROSPECTIVE COHORT |
| |
- |
THE G20210A PROTHROMBIN VARIANT (PT-G20210A) AND THE RISK OF THROMBOEMBOLISM AND FOETAL LOSS IN PREGNANT WOMEN |
| de Stefano V. |
- |
EFFICACY OF ENOXAPARIN IN PREVENTING ADVERSE FETO-MATERNAL OUTCOMES IN CARRIERS OF ANTICOAGULANTS DEFICIENCY |
| De Stefano V. |
- |
THE RISK OF PREGNANCY-RELATED VENOUS THROMBOEMBOLISM IN DOUBLE CARRIERS OF FACTOR V LEIDEN AND PROTHROMBIN G20210A |
| de Visser M.C.H. |
- |
HAPLOTYPES OF THE C-REACTIVE PROTEIN GENE, PLASMA CRP LEVELS AND THE RISK OF MYOCARDIAL INFARCTION IN MEN |
| |
- |
FACTOR IX GENE VARIANTS AND THE RISK OF VENOUS THROMBOSIS |
| |
- |
SELECTIN HAPLOTYPES AND THE RISK OF VENOUS THROMBOSIS; INFLUENCE OF LINKAGE DISEQUILIBRIUM WITH THE FACTOR V LEIDEN MUTATION |
| |
- |
POLYMORPHISMS IN THE 3'-END OF THE FIBRINOGEN GAMMA GENE AND RISK OF VENOUS THROMBOEMBOLISM IN THE AFRICAN-AMERICAN AND CAUCASIAN POPULATION |
| de Vries A.P.J. |
- |
CYTOMEGALOVIRUS AND HIGH RISK OF (RECURRENT) VENOUS THROMBOSIS AFTER RENAL TRANSPLANTATION |
| De Waele M. |
- |
IDENTIFICATION OF TWO DE NOVO ANTITHROMBIN TYPE I MUTATIONS |
| De Waele L. |
- |
DEVELOPMENT OF MEGAKARYOCYTE-SPECIFIC LENTIVIRAL VECTORS FOR GENE THERAPY OF PLATELET DISORDERS |
| de Winter R.J. |
- |
THE FACTOR VII ACTIVATING PROTEASE (FSAP) POLYMORPHISM (G534E) IS ASSOCIATED WITH A DECREASED RISK FOR RESTENOSIS AFTER PERCUTANEOUS CORONARY INTERVENTION |
| |
- |
PLATELET RECEPTOR P2Y12 HAPLOTYPES PREDICT RESTENOSIS AFTER PERCUTANEOUS CORONARY INTERVENTIONS |
| de Wit L.T. |
- |
PERIOPERATIVE PROPHYLACTIC DOSING OF TINZAPARIN IN MORBID OBESE PATIENTS |
| Debabratha D. |
- |
POLYMORPHISMS IN THE IL6 GENE IN FAMILIES WITH EARLY-ONSET CORONARY ARTERY DISEASE (CAD) -INDIAN ATHEROSCLEROSIS RESEARCH STUDY |
| Debili N. |
- |
FROM HEMATOPOIETIC STEM CELLS TO PLATELETS |
| |
- |
CALCIUM PUMPS AND ER STRESS MODULATIONS DURING THROMBOPOIESIS |
| Decavalas G. |
- |
INHERITED THROMBOPHILIA: INCIDENCE AND IMPACT ON PERINATAL OUTCOME IN SOUTH-WESTERN GREECE |
| |
- |
FV LEIDEN, FII G20210A AND MTHFR T677T GENOTYPES: IS THEIR EVALUATION A USEFUL TOOL IN THE ETIOLOGICAL APPROACH OF THE EARLY RECURRENT PREGNANCY LOSSES IN THE GREEK POPULATION? |
| Deckers J.W. |
- |
ADAMTS13 LEVELS ARE ASSOCIATED WITH THE RISK OF ARTERIAL THROMBOSIS IN YOUNG SUBJECTS |
| Deckmann A.C. |
- |
ANALYSIS OF THE GENETIC EXPRESSION OF INFLAMMATORY MEDIATORS IN MONONUCLEAR CELLS FROM DEEP VENOUS THROMBOSIS PATIENTS |
| Deckmyn H. |
- |
THE VWF-GPIB AXIS AS A THERAPEUTIC TARGET |
| |
- |
NOVEL INTERACTING PROTEINS WITH PLATELET 21 CYTOPLASMIC TAILS: RHOGDI AND SLAP-2 |
| |
- |
THE A/T1381 POLYMORPHISM IN THE A1-DOMAIN OF VON WILLEBRAND FACTOR INFLUENCES THE AFFINITY OF VON WILLEBRAND FACTOR FOR PLATELET GLYCOPROTEIN IB-ALPHA |
| |
- |
THE DISTURBED MULTIMER PATTERN OF VWF R1374C IS NOT DUE TO INCREASED ADAMTS13 MEDIATED PROTEOLYSIS |
| |
- |
CORONARY ARTERY IN-STENT STENOSIS PERSISTS DESPITE INHIBITION OF THE VON WILLEBRAND FACTOR-COLLAGEN INTERACTION IN BABOONS |
| |
- |
NOVEL PLATELET TRANSMEMBRANE PROTEINS: IDENTIFICATION AND ANALYSIS |
| |
- |
USE OF HAEMOPHILIA A ZEBRAFISH FOR SENSITIVE SCREENING AND CHARACTERISATION OF NOVEL PLATELET CANDIDATE GENES DERIVED FROM POST-GENOME STUDIES FOR PRO-THROMBOTIC FUNCTION |
| |
- |
EFFECT OF ANTI-PLATELET DRUGS ON PLATELET AGGREGATION AND THROMBUS FORMATION INDUCED BY HUMAN ATHEROSCLEROTIC PLAQUES |
| |
- |
PARATOPE AND EPITOPE MAPPING OF THE ANTITHROMBOTIC ANTIBODY 6B4 IN COMPLEX WITH PLATELET GLYCOPROTEIN IBALPHA |
| |
- |
PARATOPE AND EPITOPE MAPPING OF THE ANTITHROMBOTIC ANTIBODY 6B4 IN COMPLEX WITH PLATELET GLYCOPROTEIN IBALPHA |
| |
- |
THE HUMANIZED ANTI-GPIB MONOCLONAL ANTIBODY 6B4-FAB ABOLISHES THROMBUS FORMATION IN A MODIFIED FOLTS' MODEL IN BABOONS |
| |
- |
DECREASED ADAMTS-13 IS ASSOCIATED WITH A POOR PROGNOSIS IN SEPSIS-INDUCED ORGAN FAILURE |
| |
- |
FUNCTIONAL IN VITRO CHARACTERIZATION OF A NOVEL ADAMTS13 MUTATION (R1095W) AND POLYMORPHISM (S903L) |
| |
- |
NEW INSIGHTS IN ADAMTS13 PHYSIOLOGY BY MEASURING ACTIVITY OVER ANTIGEN RATIO |
| |
- |
RESTORATION OF VON WILLEBRAND FACTOR FUNCTION IN A MURINE MODEL OF SEVERE VON WILLEBRAND DISEASE AFTER LIVER SPECIFIC GENE TRANSFER |
| Deckmynon H. |
- |
FUNCTIONAL ANALYSIS OF HUMAN PLATELETS IN NOD/SCID MICE |
| Declerck P.J. |
- |
SIMULTANEOUS INHIBITION OF TAFI AND PAI-1 BY A HETERODIMER DIABODY |
| Declerck P. |
- |
BIOCHEMICAL AND BIOPHYSICAL CHARACTERIZATION OF AN EXTREMELY STABLE TAFI VARIANT |
| Declerck P.J. |
- |
THE BIOCHEMICAL IMPORTANCE OF GLYCOSYLATION IN THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR |
| Decousus H. |
- |
THREE-MONTH INCIDENCE OF VENOUS THROMBOEMBOLISM (VTE) IN PATIENTS WITH ISOLATED SUPERFICIAL THROMBOPHLEBITIS (ST): PRELIMINARY RESULTS OF THE POST STUDY |
| |
- |
LOW MOLECULAR WEIGHT HEPARIN (LMWH) AND CANCER SURVIVAL. A META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS IN PATIENTS WITH AND WITHOUT VTE |
| |
- |
RETRIEVABLE VENA CAVA FILTERS FOR SECONDARY PREVENTION OF PULMONARY EMBOLISM IN ORTHOPAEDIC SURGERY |
| |
- |
FONDAPARINUX IN THE TREATMENT OF SYMPTOMATIC, ISOLATED SUPERFICIAL THROMBOPHLEBITIS (ST): THE CALISTO TRIAL |
| |
- |
RISK FACTORS FOR CONCOMITANT VENOUS THROMBOEMBOLISM (VTE) IN PATIENTS WITH SUPERFICIAL THROMBOPHLEBITIS (ST): PRELIMINARY RESULTS OF THE POST STUDY |
| |
- |
RENAL IMPAIRMENT ESTIMATES TO PREDICT THE HAEMORRHAGE RISK IN 2170 PATIENTS TREATED BY HEPARIN. COCKCROFT-GAULT OR SIMPLIFIED MDRD? |
| Deda G. |
- |
SOLUBLE ENDOTHELIAL PROTEIN C RECEPTOR AND CYTOKINE LEVELS IN TURKISH PEDIATRIC STROKE PATIENTS |
| Dedja A. |
- |
RECOMBINANT HUMAN ACTIVATED PROTEIN C (RHAPC) IN PIG-TO-PRIMATE XENOTRANSPLANTATION |
| Deen P.M.T. |
- |
FUNCTIONALITY OF THE VASOPRESSIN 2 RECEPTOR VARIATION G12E AS MODIFIER OF VON WILLEBRAND FACTOR AND FACTOR VIII LEVELS |
| Degan M. |
- |
A NOVEL FLOW CYTOMETRIC METHOD FOR THE DETECTION OF RETICULATED PLATELETS BY AN ANTI-BROMODEOXYURIDINE MONOCLONAL ANTIBODY |
| Degen J.L. |
- |
FIBRIN AND FIBRINOLYSIS IN INFECTION AND HOST DEFENSE |
| Degen J. |
- |
NEONATAL LENTIVIRAL GENE TRANSFER IN A KNOCK-OUT MOUSE MODEL FOR AFIBRINOGENEMIA |
| DeGrado W.F. |
- |
THE LEECH PRODUCT SARATIN IS A POTENT INHIBITOR OF PLATELET INTEGRIN ALPHA2BETA1 AND VWF BINDING TO COLLAGEN |
| DeGroot P. |
- |
A DIMER OF B2GLYCOPROTEIN I (B2GPI) UPREGULATES TISSUE FACTOR (TF) AND IS THROMBOGENIC IN VIVO |
| Deguchi H. |
- |
RECURRENT VENOUS THROMBOEMBOLISM LINKED TO LOW PLASMA HDL |
| Deguzman F. |
- |
PRT060128, A NOVEL, DIRECT-ACTING ORALLY AVAILABLE P2Y12 ANTAGONIST, CONFERS SUPERIOR ANTITHROMBOTIC ACTIVITY OVER CLOPIDOGREL IN A MOUSE THROMBOSIS MODEL |
| Dehbozorgian J. |
- |
FACTOR XI DEFICIENCY IN SOUTHERN IRAN AND REVIEW OF LITERATURE |
| |
- |
INFLUENCE OF INHERITED THROMBOPHILIA WITH RECURRENT PREGNANCY LOSS |
| Deidda I. |
- |
ENDOGENOUS THROMBIN POTENTIAL IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOSIS |
| Deigner H.P. |
- |
BENEFICIAL EFFECTS OF ANTIPLATELET DRUGS IN SEPSIS: FIRST DATA FROM A CLINICAL AND ANIMAL STUDY |
| Deinum J. |
- |
ENZYME KINETIC CHARACTERISATION OF THE ACTIVE FORM OF THE NOVEL ORAL DIRECT THROMBIN INHIBITOR AZD0837 |
| |
- |
THE EFFECT OF DIRECT THROMBIN INHIBITORS (DTIS) IN CLOTTING PLASMA |
| Deitch J.S. |
- |
THE F11 RECEPTOR (F11R, JAM-A) IN ATHEROTHROMBOSIS: OVEREXPRESSION OF F11R IN ATHEROSCLEROTIC PLAQUES |
| Deitcher S.R. |
- |
DISCOVERY OF A POTENT, DIRECT THROMBIN INHIBITING APTAMER |
| Deitcher S.D. |
- |
PHARMACOKINETIC/PHARMACODYNAMIC PROFILE OF A NOVEL APTAMER DIRECT THROMBIN INHIBITOR IN CYNOMOLGUS MONKEYS AND YORKSHIRE PIGS FOLLOWING A SINGLE IV BOLUS ADMINISTRATION |
| Deitcher S.R. |
- |
TISSUE FACTOR/FACTOR VIIA INHIBITOR REDUCES ISCHEMIA IN PATIENTS WITH NSTE-ACS: FINAL RESULTS OF THE ANTHEM-TIMI 32 TRIAL |
| |
- |
RNAPC2, A NOVEL INHIBITOR OF TISSUE FACTOR/FACTOR VIIA COMPLEX, SYNERGIZES WITH 5-FU OR BEVACIZUMAB IN A MOUSE MODEL OF COLORECTAL CANCER |
| |
- |
RNAPC2, A NOVEL INHIBITOR OF TISSUE FACTOR/FACTOR VIIA COMPLEX, SUPPRESSES LIVER AND LUNG METASTASES IN MOUSE MODELS OF COLORECTAL CANCER |
| Dejanova V. |
- |
TREATMENT OF DIC AS A COMPLICATION OF POLYTRANSFUSION AT PATIENT WITH OBSTETRIC HEMORRHAGE-CASE REPORT |
| Del Carpio-Cano F.E. |
- |
A PROSPECTIVE STUDY OF PATIENTS WITH CANCER WITH A SHORT ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) IN THE ABSENCE OF THROMBOSIS |
| Del Pace S. |
- |
DO HIGH SENSITIVITY C-REACTIVE PROTEIN AND CYSTATIN-C SERUM LEVELS PREDICT TOTAL MORTALITY IN HEART FAILURE PATIENTS? |
| |
- |
B-GROUP VITAMINS' PROFILE AND OCCURRENCE OF CORONARY ARTERY DISEASE: A CASE-CONTROL STUDY |
| del Valle-Mondragon L. |
- |
EFFECT OF PROLAME, A 17 BETA-AMINOESTROGEN DERIVATIVE, ON CELL HEMOSTASIS |
| Del Vecchio L.L.D. |
- |
A B3 ASP217VAL SUBSTITUTION IN A PATIENT WITH VARIANT GLANZMANN THROMBATHENIA SEVERELY AFFECTS INTEGRIN AIIBB3 FUNCTIONS |
| del Zoppo G.J. |
- |
PLASSMINOGEN ACTIVATORS AND PROTEASES IN ISCHEMIC STROKE |
| DeLa Cadena R.A. |
- |
ELEVATED PLASMA LEVELS OF THROMBOSPONDIN-1 (TSP1) ARE ASSOCIATED WITH INCREASED LEVELS OF TGF-BETA AND PRO-INFLAMMATORY CYTOKINES IN RHEUMATOID ARTHRITIS PATIENTS |
| |
- |
A PROSPECTIVE STUDY OF PATIENTS WITH CANCER WITH A SHORT ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) IN THE ABSENCE OF THROMBOSIS |
| |
- |
THROMBOSPONDIN-1 (TSP1) PROMOTES THROMBIN GENERATION ON THE SURFACE OF FIBROBLASTS (HS-68) AND INDUCES UPREGULATION OF CONNECTIVE TISSUE GROWTH FACTOR (CTGF) GENE AND PROTEIN EXPRESSION |
| dela Cruz R.C. |
- |
CONCURRENT RELEASE OF NATIVE CONFORMATION REACTIVE CENTER LOOP AND HELIX D STRAND 2A STRUCTURAL CONSTRAINTS FULLY ACTIVATES ANTITHROMBIN III IN THE ABSENCE OF HEPARIN |
| Delahousse B. |
- |
ASSOCIATION BETWEEN THE HOMOZYGOUS STATUS FOR THE 807T ALLELE OF ITGA2 AND RETINAL ARTERY OCCLUSION |
| |
- |
INFLUENCE OF THE SOURCE OF PHOSPHOLIPIDS FOR APTT-BASED FIX ASSAYS AND POTENTIAL CONSEQUENCES FOR THE DIAGNOSIS OF MILD/MODERATE HAEMOPHILIA B |
| |
- |
IS THE RISK OF VENOUS THROMBOEMBOLISM HIGHER WITH CYPROTERONE CONTRACEPTIVES? |
| Delaini F. |
- |
A SURVEY ON POST-SURGERY OUTCOMES IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA IN A RETROSPECTIVE COHORT |
| Delaney J.A. |
- |
WARFARIN USE AND THE DECREASED RISK OF PROSTATE CANCER |
| Delatte P. |
- |
RECURRENT ARTERIAL THROMBOSIS WITH FACTOR V LEIDEN HOMOZYGOCY |
| Delecroix M. |
- |
AN OBSERVATIONAL COHORT OF PATIENTS UNDERGOING FONDAPARINUX THROMBOPROPHYLAXIS AFTER ROUTINE ORTHOPEDIC SURGERY (OS): THE ARISTOTE STUDY |
| Delev D. |
- |
PSEUDO-HOMOZYGOUS APC RESISTANCE DUE TO COINHERITANCE OF HETEROZYGOUS FACTOR V-R506Q AND FV TYPE I DEFICIENCY |
| Delignat S. |
- |
COMPARISON OF THE IMMUNOGENICITY OF DIFFERENT THERAPEUTIC PREPARATIONS OF HUMAN FACTOR VIII IN THE MURINE MODEL OF HEMOPHILIA A |
| |
- |
IDENFICATION OF THE RECEPTORS IMPLICATED IN THE ENDOCYTOSIS OF FACTOR VIII BY HUMAN DENDRITIC CELLS |
| |
- |
EXPOSED MANNOSYLATION ON THERAPEUTIC FACTOR VIII MEDIATES ITS ENDOCYTOSIS BY HUMAN DENDRITIC CELLS LEADING TO ACTIVATION OF CD4+ T LYMPHOCYTES |
| |
- |
VWF INHIBITS OF THE ENDOCYTOSIS OF FACTOR VIII BY MURINE BONE MARROW-DERIVED DENDRITIC CELLS |
| Della Corte A. |
- |
DIFFERENTIAL ANALYSIS BY 2-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS (2D-DIGE) OF HUMAN PLATELET PROTEINS RELEASED FOLLOWING THROMBIN ACTIVATION: IDENTIFICATION OF LAMIN A, A NOVEL PLATELET PROTEIN |
| Della Valle P. |
- |
PATIENTS WITH LUPUS ANTICOAGULANTS AND HISTORY OF THROMBOSIS CARRY ANTIBODIES TO BETA2-GLYCOPROTEIN I INHIBITING THE PHOSPHOLIPID OXIDATION-DEPENDENT ACTIVITY OF APC |
| Dell'Elba G. |
- |
ANTI-INFLAMMATORY EFFECS OF CLOPIDOGREL IN THE MOUSE |
| |
- |
PERSISTENT PLATELET ACTIVATION IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH LOW DOSES OF ASPIRIN |
| Dell'Era A. |
- |
THE INTERNATIONAL NORMALIZED RATIO TO PRIORITIZE PATIENTS FOR LIVER TRANSPLANTATION. PROBLEMS AND SOLUTIONS |
| Dellstrand M. |
- |
EFFECT OF THE ORAL DIRECT THROMBIN INHIBITOR AZD0837 ON GLOMERULAR FILTRATION RATE IN ELDERLY HEALTHY SUBJECTS |
| Delluc A. |
- |
BODY MASS INDEX, MILD HYPERHOMOCYSTEINEMIA AND VENOUS THROMBOEMBOLISM RISK |
| Deloukas P. |
- |
A COMPREHENSIVE STUDY OF CANDIDATE GENES IN TWO SIGNALLING PATHWAYS TO IDENTIFY GENETIC VARIANTS THAT REGULATE PLATELET RESPONSIVENESS TO COLLAGEN AND ADP |
| Delumeau J.C. |
- |
AN OBSERVATIONAL STUDY OF SUCROSE-FORMULATED RECOMBINANT FACTOR VIII FOR JAPANESE PATIENTS WITH HEMOPHILIA A |
| Demarsin E. |
- |
THE HUMANIZED ANTI-GPIB MONOCLONAL ANTIBODY 6B4-FAB ABOLISHES THROMBUS FORMATION IN A MODIFIED FOLTS' MODEL IN BABOONS |
| Demchenko M.A. |
- |
NONSPECIFIC BINDING OF CIRCULATED IMMUNOGLOBULINS TO THE ENDOTHELIAL SELLS OF BLOOD VESSELS |
| Demers C. |
- |
LINKAGE ANALYSIS FOR NORMAL PROTEIN C LEVELS IN A PROTEIN C-DEFICIENT FAMILY |
| Demetrio M. |
- |
DIFFERENT PATTERN OF TF EXPRESSION IN PLATELETS, LEUKOCYTES AND AGGREGATES OF CAD PATIENTS |
| Demidova E.M. |
- |
GENETIC POLYMORPHISM R353Q OF FACTOR VII HAS PROTECTIVE EFFECT IN THREATENED MISCARRIAGE |
| Demir M. |
- |
COMPARATIVE STUDY ON THE ANTICOAGULANT EFFECTS OF UNFRACTIONATED AND LOW MOLECULAR WEIGHT HEPARINS, LOWER LOW MOLECULAR WEIGHT HEPARINS AND PENTASACCAHRIDE AS MEASURED BY WHOLE BLOOD ACT, ANTI-XA AND A NEWLY DEVELOPED PROTHROMBINASE INDUCED CLOTTING TIME |
| |
- |
THROMBOSIS IN PATIENTS WITH LUNG CANCER AND THE EFFECTIVENESS OF LOW WARFARIN PROPHYLAXIS ON PATIENTS' SURVIVAL |
| |
- |
UPREGULATION OF INFLAMMATORY MEDIATORS IN LUNG CANCER AND THEIR MODULATION BY ORAL ANTICOAGULANT THERAPY |
| |
- |
LONGITUDINAL OBSERVATION OF TAFI LEVELS ALONG NORMAL PREGNANCY AND PUERPERIUM: RELATIONSHIP BETWEEN TAFI AND OTHER MARKERS OF FIBRINOLYSIS |
| |
- |
IS PLATELET HYPERREACTIVITY DEFINING STICKY PLATELET SYNDROME A GLOBAL PHENOMENON? THE STUDY OF DETERMINATON OF NORMAL VALUES IN TURKISH HEALTHY SUBJECTS |
| |
- |
INCIDENCE OF ANTI-HEPARIN/PLATELET FACTOR 4 (AHPF4) ANTIBODIES AND HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) IN MEDICAL PATIENTS |
| Demirkan F. |
- |
THE EFFECT OF EXERCISE ON FIBRINOLYTIC AND COAGULATION SYSTEMS IN HEALTHY VOLUNTEERS |
| Demolis J. |
- |
EFFECT OF TWO DOSES OF ORAL OESTROGEN REPLACEMENT THERAPY ON THE PROTEIN C SYSTEM IN POSTMENOPAUSAL WOMEN. A RANDOMISED DOUBLE BLIND PLACEBO-CONTROLLED STUDY |
| den Heijer M. |
- |
APOLIPOPROTEIN A1 AS A PREDICTOR OF RECURRENT VENOUS THROMBOSIS. RESULTS OF A PLASMA PROTEOMICS APPROACH |
| |
- |
COMPRESSION BANDAGING IN THE ACUTE PHASE OF DEEP-VEIN THROMBOSIS IN RELATION TO THE POST-THROMBOTIC SYNDROME |
| |
- |
ELEVATED MARKERS OF INFLAMMATION IN THE ACUTE PHASE OF DEEP-VEIN THROMBOSIS ARE A RISK FACTOR FOR ELEVATED VENOUS RESISTANCE AS A PROXY OF THE POST-THROMBOTIC SYNDROME |
| |
- |
ANALYSIS OF FOLATE-RELATED GENES FOR ASSOCIATION WITH PLASMA HOMOCYSTEINE LEVEL IN A SNP-MICROARRAY APPROACH |
| |
- |
CATECHOL-O-METHYLTRANSFERASE GENOTYPE IS ASSOCIATED WITH PLASMA TOTAL HOMOCYSTEINE LEVELS AND MAY INCREASE RECURRENT VENOUS THROMBOSIS RISK |
| |
- |
THE NIJMEGEN HAEMOSTASIS ASSAY (NHA) IN THE VITRO-STUDY: RELATION WITH HOMOCYSTEINE, B-VITAMIN TREATMENT AND RECURRENCE RISK |
| |
- |
B-VITAMIN SUPPLEMENTATION LOWERS PLASMA HOMOCYSTEINE CONCENTRATION BUT DOES NOT AFFECT PLASMA METHIONINE AND CYSTEINE CONCENTRATIONS: A POSSIBLE EXPLANATION FOR NEGATIVE RESULTS OF CLINICAL TRIALS |
| |
- |
SINGLE AND COMBINED EFFECTS OF GENE VARIANTS ON PLASMA TOTAL HOMOCYSTEINE LEVELS: RESULTS OF A CANDIDATE GENE APPROACH IN A POPULATION SAMPLE |
| Den Heijer M. |
- |
TWO NOVEL MUTATIONS AND FOUR NOVEL POLYMORPHISMS IN THE FACTOR VII GENE |
| Deneys V. |
- |
EVALUATION OF THE EFFECTS OF A SINGLE INFUSION OF FACTOR VIII ON WHOLE BLOOD COAGULATION THROMBOELASTOGRAPHY IN PATIENTS WITH SEVERE HAEMOPHILIA |
| |
- |
EVALUATION OF THROMBOPHILIA SCREENING IN WOMEN WITH OBSTETRICAL COMPLICATIONS: A "REAL WORLD" EXPERIENCE |
| |
- |
DETERMINATION OF VKORC1 AND CYP2C9 GENOTYPES IS OF LIMITED VALUE DURING CHRONIC ANTICOAGULATION WITH ACENOCOUMAROL |
| |
- |
MONITORING AND DOSAGE MODULATION OF ENOXAPARIN DURING PREGNANCY |
| Denis C.V. |
- |
PSGL1 AND LDL-RECEPTORS MEDIATE ADHESION OF LEUKOCYTES TO BETA2-GLYCOPROTEIN-I |
| |
- |
LIVER AND SPLEEN MACROPHAGES CONTRIBUTE TO THE CLEARANCE OF VON WILLEBRAND FACTOR AND ITS COMPLEX WITH FACTOR VIII |
| |
- |
A MURINE MODEL TO ASSESS VON WILLEBRAND FACTOR FUNCTION IN VIVO |
| Dentali F. |
- |
INHERITED THROMBOPHILIC ABNORMALITIES AND RISK OF PORTAL VEIN THROMBOSIS: A META-ANALYSIS |
| |
- |
SHOULD COMMON INERITED THROMBOPHILIC ABNORMALITIES BE TESTED IN CANCER PATIENT WITH CENTRAL VENOUS CATHETER? |
| |
- |
VENOUS THROMBOEMBOLIC COMPLICATIONS IN PATIENTS UNDERGOING CHEST SURGERY FOR LUNG OR PLEURAL MALIGNANT DISEASE |
| |
- |
BRAIN NATRIURETIC PEPTIDE AS A PRECLINICAL MARKER OF CHRONIC PULMONARY HYPERTENSION IN PATIENTS WITH PULMONARY EMBOLISM |
| |
- |
METABOLIC SYNDROME AND HYPERHOMOCYSTEINEMIA IN PATIENTS WITH DEEP VEIN THROMBOSIS: A CASE-CONTROL STUDY |
| Dentand I. |
- |
ANTICOAGULANT HEPARAN SULFATES MODULATE TISSUE REMODELING AT OVULATION |
| Deom A. |
- |
EVALUATION OF THE COAGUCHEK XS PLUS SYSTEM IN A SWISS COMMUNITY SETTING |
| Depasse F. |
- |
THREE DIFFERENT PATTERNS OF CALIBRATED AUTOMATED THROMBOGRAM OBTAINED WITH HIRUDIN, MELAGATRAN, DABIGATRAN, ARGATROBAN, FONDAPARINUX AND DANAPAROD |
| DePaulis A.I. |
- |
HEPARIN INDUCED THROMBOCYTOPENIA: COMPLIANCE WITH GUIDELINES IN A LARGE COMMUNITY HOSPITAL |
| Derksen R.H.M.W. |
- |
ACTIVATION OF PLATELETS BY DIMERIC 2-GLYCOPROTEIN I REQUIRES SIGNALING VIA BOTH GLYCOPROTEIN IBalpha AND APOLIPOPROTEIN E RECEPTOR 2' |
| Derksen R.H.W.M. |
- |
DIMERIC 2-GPI BINDS TO LDL-BINDING DOMAIN 1 OF APOER2. PLATELETS EXPRESS THREE 3 DIFFERENT SPLICE VARIANTS OF APOER2 OF WHICH APOER24-5 IS THE MOST ABUNDANT |
| Desai H. |
- |
THERAPEUTIC ANTIBODIES AGAINST CD40 LIGAND, TNF-ALPHA AND VEGF SHARE MECHANISTIC FEATURES IN COMMON WITH PLATELET ACTIVATING ANTIBODIES IN HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) |
| |
- |
HYPERCOAGULABILITY IN OVARIAN CANCER REVISITED: A PROSPECTIVE ANALYSIS OF COAGULATION AND PLATELET ACTIVATION MARKERS |
| Desai S. |
- |
POST-THROMBOTIC SYNDROME IN CHILDREN SURVIVING ACUTE LYMPHOBLASTIC LEUKEMIA |
| Desai H. |
- |
PROSPECTIVE EVALUATION OF LABORATORY TESTS FOR THE DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA |
| De-Sá-Júnior P.L. |
- |
AMBLYOMIN-X IN CULTURED CANCER CELLS: CITOTOXICITY AND CELL CYCLE EFFECTS |
| DeSantis D.J. |
- |
HETEROZYGOUS FIBRINOGEN GAMMA-114 TYR-HIS MUTATION ASSOCIATED WITH RESISTANCE TO TPA-MEDIATED FIBRINOLYSIS AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION |
| |
- |
HETEROZYGOUS FIBRINOGEN GAMMA-375 ARG-TRP MUTATION ASSOCIATED WITH EXCESSIVE SIALYLATION, PLASMIN RESISTANCE AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION |
| Descalzi V. |
- |
FACTOR V IS AN INDEPENDENT PREDICTOR OF MORTALITY IN PATIENTS WITH CIRRHOSIS: USEFUL TOOL IN PATIENTS WAITING FOR LIVER TRANSPLANTATION |
| Descarpentries C. |
- |
IS MODIFICATION OF DIET IN RENAL DISEASE (MDRD) FORMULA SIMILAR TO COCKCROFT-GAULT FORMULA TO ASSESS RENAL FUNCTION IN ELDERLY HOSPITALIZED PATIENTS TREATED WITH LOW MOLECULAR WEIGHT HEPARIN (LMWH)? |
| Desch K. |
- |
MUTATIONS THAT RENDER VON WILLEBRAND FACTOR (VWF) RESISTANT TO ADAMTS13 CLEAVAGE |
| Deschamps A. |
- |
BIOLOGICAL ASSAY OF ASPIRIN-RESISTANCE: ULTRASTRUCTURE OF PLATELET GLYCOPROTEIN REDISTRIBUTION AFTER ARACHIDONIC ACID ACTIVATION AND ASPIRIN INHIBITION, AND COMPARISON WITH USUAL LABORATORY TESTS |
| Deschepper N. |
- |
USE OF SOLUBLE FIBRIN MONOMER (SFM) WITH DDIMER (DDI) AND THE ISTH SCORE MAY AID IN DIAGNOSIS OF DIC |
| DeSilva T. |
- |
IDENTIFICATION OF POTENT CYCLIC PEPTIDES THAT BIND TO PLATELET GLYCOPROTEIN IB ALPHA AND SELECTIVELY INHIBIT VON WILLEBRAND FACTOR DEPENDENT HIGH-SHEAR PLATELET AGGREGATION |
| Desjardins L. |
- |
PERSISTENT VENOUS SYMPTOMS AND SIGNS 1 MONTH AFTER A FIRST DIAGNOSIS OF DVT PREDICT DEVELOPMENT OF THE POST-THROMBOTIC SYNDROME (PTS) DURING 2 YEARS FOLLOW-UP |
| Desmarais S. |
- |
PERSISTENT VENOUS SYMPTOMS AND SIGNS 1 MONTH AFTER A FIRST DIAGNOSIS OF DVT PREDICT DEVELOPMENT OF THE POST-THROMBOTIC SYNDROME (PTS) DURING 2 YEARS FOLLOW-UP |
| Dessomme B. |
- |
EVALUATION OF THE EFFECTS OF A SINGLE INFUSION OF FACTOR VIII ON WHOLE BLOOD COAGULATION THROMBOELASTOGRAPHY IN PATIENTS WITH SEVERE HAEMOPHILIA |
| |
- |
DETERMINATION OF VKORC1 AND CYP2C9 GENOTYPES IS OF LIMITED VALUE DURING CHRONIC ANTICOAGULATION WITH ACENOCOUMAROL |
| |
- |
MONITORING AND DOSAGE MODULATION OF ENOXAPARIN DURING PREGNANCY |
| Dethlefsen C. |
- |
EPIDEMIOLOGICAL STUDY OF VENOUS THROMBOEMBOLISM IN A BIG DANISH COHORT |
| Deutsch V.R. |
- |
ENHANCED VIABILITY AND EX VIVO EXPANSION AND MATURATION OF CORD BLOOD MEGAKARYOCYTE PROGENITORS (MK-P) WITH FIBRONECTIN |
| Deutsch V. |
- |
HEPARANASE MODULATES HEPARINOIDS ANTICOAGULANT ACTIVITIES VIA NON-ENZYMATIC MECHANISMS |
| Deutz N.E.P. |
- |
ARGININE THERAPY TENDS TO REDUCE ENDOTHELIAL DAMAGE IN SEPSIS |
| Devadharshini M. |
- |
POLYMORPHISMS IN COAGULANT AND INFLAMMATORY GENES MODIFY THE PHENOTYPE OF SEVERE HEMOPHILIA A AND B |
| Devantéry C. |
- |
ANTICOAGULANT HEPARAN SULFATES MODULATE TISSUE REMODELING AT OVULATION |
| deVeber G. |
- |
TPA IN CHILDREN WITH ARTERIAL ISCHEMIC STROKE: CASES FROM THE IPSS COMPARED WITH LITERATURE-BASED CASES |
| |
- |
HEMORRHAGIC TRANSFORMATION OF ARTERIAL ISCHEMIC STROKE IN CHILDREN |
| |
- |
THE SAFETY OF ANTICOAGULANTS IN PEDIATRIC ARTERIAL ISCHEMIC STROKE: PRELIMINARY RESULTS |
| DeVeber G. |
- |
PAEDIATRIC STROKE |
| |
- |
OCCIPITAL BONE COMPRESSION OF THE SUPERIOR SAGITTAL SINUS AS A CONTRIBUTORY FACTOR IN NEONATAL CEREBRAL SINOVENOUS THROMBOSIS |
| Develter J. |
- |
SIMULTANEOUS INHIBITION OF TAFI AND PAI-1 BY A HETERODIMER DIABODY |
| Devens B. |
- |
SITE-SPECIFIC PEGYLATION OF RFVIII RESULTS IN PROLONGED IN VIVO EFFICACY |
| Devine D.V. |
- |
APPLICATION OF PROTEOMICS TO THE IDENTIFICATION OF PROTEINS ASSOCIATED WITH THE PLATELET STORAGE LESION AND THEIR TRANSLATION |
| Devocelle M. |
- |
A TAILOR-MADE PEPTIDE-AFFINITY COLUMN TO IDENTIFY NOVEL BINDING PARTNERS FOR A CYTOPLASMIC MOTIF OF THE PLATELET INTEGRIN ALPHA IIB |
| Devold H. |
- |
DETERMINATION OF TISSUE FACTOR ORIGIN USING SIRNA KNOCKDOWN APPROACH IN HUMAN PERIPHERAL BLOOD WHITE CELLS |
| Devreese K.M.J. |
- |
DIAGNOSIS OF THE ANTIPHOSPHOLIPID SYNDROME BY CALIBRATED AUTOMATED THROMBINOGRAPHY |
| Dewald G. |
- |
COAGULATION FACTOR XII MISSENSE MUTATIONS (T309K, T309R) IN HEREDITARY ANGIOEDEMA WITH NORMAL C1 INHIBITOR |
| Dewan U. |
- |
ROLE OF HEMATOLOGIC AND SCREENING HEMOSTATIC PROFILE ON ADMISSION, IN PREDICTION OF DEVELOPMENT OF COMPLICATIONS IN HOSPITALIZED PATIENTS WITH DENGUE FEVER |
| Dewhurst L. |
- |
TRENDS IN FVIII AND FIX USE IN THE UNITED KINGDOM 2001-2006 |
| Dewilde M. |
- |
SIMULTANEOUS INHIBITION OF TAFI AND PAI-1 BY A HETERODIMER DIABODY |
| Dezfouli S. |
- |
MICE TRANSGENIC FOR THROMBOMODULIN EXHIBIT PROTECTION FROM VENOUS THROMBOSIS |
| Dhanasekaran D. |
- |
PHORBOL 12-MYRISTATE 13-ACETATE (PMA) RESPONSIVE SEQUENCE IN G ALPHA Q PROMOTER DURING MEGAKAYOCYTIC DIFFERENTIATION: REGULATION BY EGR-1 |
| Di Bari F. |
- |
MUTATED POSITION OF NMHC-A PREDICTS THE NATURAL HISTORY OF MYH9-RELATED DISEASE |
| |
- |
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA (CAMT): CLINICAL AND BIOLOGICAL CHARACTERIZATION OF FIVE NEW MUTATIONS |
| Di Capua M. |
- |
ACQUIRED AND INHERITED PREDISPOSING CONDITIONS IN PATIENTS WITH RETINAL VEIN OCCLUSION |
| |
- |
LOW INSULIN-LIKE GROWTH FACTOR (IGF) I, IGF BINDING PROTEIN-3 AND ACID LABILE SUBUNIT (ALS) LEVELS IN YOUNG ISCHEMIC STROKE: A PROSPECTIVE CASE-CONTROL STUDY |
| |
- |
PREDISPOSING FACTORS IN PATIENTS WITH EARLY-ONSET CEREBRAL VEIN THROMBOSIS |
| Di Castelnuovo A. |
- |
INTERLEUKINS GENES TAG-SNP HAPLOTYPES AND RISK OF MYOCARDIAL INFARCTION: A POPULATION BASED CASE-CONTROL STUDY |
| |
- |
ASSOCIATION OF C-REACTIVE PROTEIN AND ALCOHOL INTAKE IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION |
| |
- |
ASSOCIATION OF C-REACTIVE PROTEIN AND WHITE BLOOD CELL COUNT WITH PHYSICAL ACTIVITY IN HEALTHY SUBJECTS |
| |
- |
TISSUE FACTOR GENE TAG-SNPS AND HAPLOTYPES AND THE RISK OF MYOCARDIAL INFARCTION |
| |
- |
FIBRIN D-DIMERS IS ASSOCIATED WITH PREVALENT CARDIOVASCULAR EVENTS IN THE MOLI-SANI STUDY |
| |
- |
ASSOCIATION OF C-REACTIVE PROTEIN, OBESITY AND METABOLIC SYNDROME IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION |
| |
- |
INTERLEUKIN-1B GENE HAPLOTYPES AND INFLAMMATORY/PROCOAGULANT RESPONSE OF HUMAN MONONUCLEAR CELLS |
| |
- |
RESPONSE VARIABILITY TO ASPIRIN AS ASSESSED BY A PLATELET FUNCTION-ANALYZING DEVICE IN 5,007 SUBJECTS: A SYSTEMATIC REVIEW OF 40 STUDIES |
| Di Cera E. |
- |
THE THROMBIN MUTANT W215A/E217A ACTS AS A PLATELET ANTAGONIST THROUGH INHIBITION OF THROMBIN ACTIVATION AND GPIB BINDING TO VWF |
| |
- |
PROTEIN C ACTIVATOR (PCA) INTERRUPTION OF THROMBUS PROPAGATION WITHOUT ANTIHEMOSTATIC SIDE EFFECT IN PRIMATES |
| |
- |
PROTEIN C ACTIVATOR (PCA) TREATMENT IMPROVES THE NEUROLOGICAL OUTCOME OF EXPERIMENTAL THROMBOTIC ISCHEMIC STROKE IN MICE |
| |
- |
THROMBIN AS PROCOAGULANT AND ANTICOAGULANT |
| Di Fazio B. |
- |
ANKLE REPLACEMENT IN SEVERE BLEEDING DISORDERS: RETROSPECTIVE STUDY ON 17 CASES |
| Di Febbo C. |
- |
LEPTIN INDUCES TISSUE FACTOR EXPRESSION IN HUMAN MONOCYTES |
| Di Francesco E. |
- |
PLASMA COAGULATION TESTS AND GENETIC THROMBOPHILIC MUTATION STUDIES ARE MANDATORY FOR PREVENTING THE IDIOPATHIC RECURRENT ABORTIONS OR REPEATED FETAL LOSS IN HEALTHY WOMEN |
| |
- |
THE THERAPEUTICAL STRATEGIES ARE EFFECTIVE TO PREVENT THE RECURRENT ABORTIONS, REPEATED FETAL LOSS OR THE INTRAUTERINE FETAL GROWTH RETARDATION IN WOMEN WITH COAGULATION ABNORMALITIES AND/OR GENETIC THROMBOPHILIC MUTATIONS |
| Di Franco M. |
- |
RELATIONSHIP BETWEEN INFLAMMATORY INDEXES ON ADMISSION AND DIAGNOSIS OF ACUTE AORTIC DISSECTION |
| Di Gaetano R. |
- |
PRENATAL DIAGNOSIS OF HAEMOPHILIA A BY USING INTRON 1 INVERSION MUTATION |
| |
- |
UPDATE OF THE ITALIAN HAEMOPHILIA B MUTATION DATABASE |
| Di Giammarco G. |
- |
SURGICAL BLEEDING AFTER PREOPERATIVE UNFRACTIONATED HEPARIN AND LOW MOLECULAR WEIGHT HEPARIN AT CORONARY BYPASS SURGERY |
| di Giuseppe R. |
- |
FIBRIN D-DIMERS IS ASSOCIATED WITH PREVALENT CARDIOVASCULAR EVENTS IN THE MOLI-SANI STUDY |
| |
- |
ASSOCIATION OF C-REACTIVE PROTEIN, OBESITY AND METABOLIC SYNDROME IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION |
| |
- |
ASSOCIATION OF C-REACTIVE PROTEIN AND ALCOHOL INTAKE IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION |
| |
- |
ASSOCIATION OF C-REACTIVE PROTEIN AND WHITE BLOOD CELL COUNT WITH PHYSICAL ACTIVITY IN HEALTHY SUBJECTS |
| Di Martino E. |
- |
BIOCHEMICAL AND MECHANICAL PROPERTIES OF INTRALUMINAL THROMBUS FROM HUMAN ABDOMINAL AORTIC ANEURYSM |
| Di Minno G. |
- |
IMMUNE TOLERANCE INDUCTION (ITI) IN PATIENTS WITH HEMOPHILIA A AND INHIBITORS: THE ITALIAN RETROSPECTIVE-PROSPECTIVE REGISTRY - THE PROFIT STUDY |
| |
- |
BUDD-CHIARI SYNDROME IN A PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENT WITH PREVIOUS CEREBRAL VENOUS THROMBOSIS |
| |
- |
PAI-1 GENE HAPLOTYPES ARE ASSOCIATED WITH MYOCARDIAL INFARCTION OCCURRENCE IN NON SMOKERS: THE HIFMECH STUDY |
| |
- |
PREDISPOSING FACTORS IN PATIENTS WITH EARLY-ONSET CEREBRAL VEIN THROMBOSIS |
| |
- |
RIGHT-TO-LEFT SHUNT, ATRIAL SEPTAL ANEURYSM AND THROMBOPHILIA IN PATIENTS WITH CRYPTOGENIC STROKE OR TIA VERSUS THOSE WITH VENOUS THROMBOEMBOLISM |
| Di Minno M.N.D. |
- |
LOW INSULIN-LIKE GROWTH FACTOR (IGF) I, IGF BINDING PROTEIN-3 AND ACID LABILE SUBUNIT (ALS) LEVELS IN YOUNG ISCHEMIC STROKE: A PROSPECTIVE CASE-CONTROL STUDY |
| Di Minno G. |
- |
LOW INSULIN-LIKE GROWTH FACTOR (IGF) I, IGF BINDING PROTEIN-3 AND ACID LABILE SUBUNIT (ALS) LEVELS IN YOUNG ISCHEMIC STROKE: A PROSPECTIVE CASE-CONTROL STUDY |
| |
- |
DESMOPRESSIN IN PATIENTS WITH CONGENITAL DISORDERS OF PRIMARY HAEMOSTASIS: FOUR YEAR PROSPECTIVE EVALUATION |
| |
- |
FACTOR VIII (F8) GENE MUTATIONS AND IMMUNE TOLERANCE INDUCTION (ITI) IN HAEMOPHILIA A WITH INHIBITORS: DATA FROM THE ITALIAN ITI REGISTRY (THE PROFIT STUDY) |
| Di Minno M. |
- |
INSULIN-DEPENDENT CHANGES IN PAI-1 AND T-PA LEVELS AFTER A 6-MO TREATMENT WITH R-HGH IN GROWTH HORMONE DEFICIENT (GHD) ADULTS |
| Di Minno M.N.D. |
- |
ACQUIRED AND INHERITED PREDISPOSING CONDITIONS IN PATIENTS WITH RETINAL VEIN OCCLUSION |
| Di Paola J. |
- |
CRITICAL ROLE FOR CYCLOPHILIN D (CYPD) AND THE MITOCHONDRIAL PERMEABILITY TRANSITION PORE (MPTP) IN THE REGULATION OF PLATELET ACTIVATION AND THROMBOSIS |
| Di Paolo H. |
- |
THROMBOPHILIA AND ISCHEMIC STROKE: A RETROSPECTIVE STUDY |
| Di Pillo R. |
- |
SURGICAL BLEEDING AFTER PREOPERATIVE UNFRACTIONATED HEPARIN AND LOW MOLECULAR WEIGHT HEPARIN AT CORONARY BYPASS SURGERY |
| Di Renzo L. |
- |
PERSISTENT TXA2 PRODUCTION IN PATIENTS CHRONICALLY TREATED WITH ASPIRIN: RESIDUAL COX-1 ACTIVITY OR COX-2 ACTIVATION? |
| Di Santo A. |
- |
GLYCOGEN SYNTHASE KINASE-3 NEGATIVELY REGULATES TISSUE FACTOR GENE EXPRESSION IN MONOCYTES INTERACTING WITH ACTIVATED PLATELETS |
| |
- |
LEPTIN INDUCES TISSUE FACTOR EXPRESSION IN HUMAN MONOCYTES |
| Di Santo S. |
- |
LDL-CHOLESTEROL ENHANCES PLATELET RECRUITMENT VIA GP91PHOX-MEDIATED CD40L UPREGULATION |
| |
- |
EARLY INCREASE OF OXIDATIVE STRESS AND SOLUBLE CD40L IN CHILDREN |
| |
- |
LDL ARE OXIDATIVELY MODIFIED BY PLATELETS VIA GP91PHOX |
| Di Sanza C. |
- |
RESCUE IN VITRO OF SECRETION-DEFECTIVE FIBRINOGEN MUTANTS CAUSING AFIBRINOGENEMIA |
| Di Somma C. |
- |
INSULIN-DEPENDENT CHANGES IN PAI-1 AND T-PA LEVELS AFTER A 6-MO TREATMENT WITH R-HGH IN GROWTH HORMONE DEFICIENT (GHD) ADULTS |
| |
- |
LOW INSULIN-LIKE GROWTH FACTOR (IGF) I, IGF BINDING PROTEIN-3 AND ACID LABILE SUBUNIT (ALS) LEVELS IN YOUNG ISCHEMIC STROKE: A PROSPECTIVE CASE-CONTROL STUDY |
| Di Stasio E. |
- |
MECHANISMS OF INHIBITION OF THROMBIN-INDUCED PLATELET ACTIVATION BY FIBRINOGEN GAMMA'(408-427) PEPTIDE |
| |
- |
EFFECT OF PH AND TEMPERATURE ON ADAMTS-13 CATALYSIS |
| Di Stazio M. |
- |
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA (CAMT): CLINICAL AND BIOLOGICAL CHARACTERIZATION OF FIVE NEW MUTATIONS |
| Di Stefano I. |
- |
FIBRIN D-DIMERS IS ASSOCIATED WITH PREVALENT CARDIOVASCULAR EVENTS IN THE MOLI-SANI STUDY |
| |
- |
ASSOCIATION OF C-REACTIVE PROTEIN, OBESITY AND METABOLIC SYNDROME IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION |
| |
- |
ASSOCIATION OF C-REACTIVE PROTEIN AND WHITE BLOOD CELL COUNT WITH PHYSICAL ACTIVITY IN HEALTHY SUBJECTS |
| |
- |
ASSOCIATION OF C-REACTIVE PROTEIN AND ALCOHOL INTAKE IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION |
| Di Vagno G. |
- |
TF EXPRESSION IN HUMAN PLACENTA IS SIGNIFICANTLY ASSOCIATED WITH VEGF EXPRESSION |
| Di Virgilio F. |
- |
RELEASE OF TISSUE FACTOR-BEARING MICROPARTICLES BY HUMAN DENDRITIC CELLS INDUCED BY STIMULATION OF MEMBRANE P2X7 RECEPTORS |
| Diacovo T.G. |
- |
GENETIC MODIFICATION OF A SPECIES-DIVERGENT BOND IN VWF-A1 PEMITS HUMAN PLATELET THROMBUS FORMATION IN MICE |
| Diamandis M. |
- |
IDENTIFICATION OF A LOCUS FOR THE QUEBEC PLATELET DISORDER USING GENETIC LINKAGE ANALYSIS |
| Diamant M. |
- |
SIMVASTATIN-INDUCED ENDOTHELIAL CELL DETACHMENT AND MICROPARTICLE RELEASE ARE PRENYLATION DEPENDENT |
| Dias D. |
- |
ROLE OF PLATELET GLYCOPROTEIN IB-ALPHA POLYMORPHISM IN PLATELET REACTIVITY |
| Diasamidze K. |
- |
USE OF RECOMBINANT FACTOR VIIA IN CARDIOSURGERY PATIENTS, INCLUDING NEONATES AND INFANTS UNDER 1 YEAR OF AGE |
| Diaz D. |
- |
ILPCA, A RECOMBINANT PC ACTIVATOR SUCCESSFULLY USED TO FORMULATE AN AUTOMATED PC CHROMOGENIC ASSAY IN LIQUID FORMAT |
| Díaz G. |
- |
DEEP VEIN THROMBOSIS AND THE RISK OF RECURRENT PULMONARY EMBOLISM |
| Diaz D. |
- |
THROMBOPATH KIT CORRELATES BETTER WITH FREE PROTEIN S TO PROTHROMBIN RATIO AND FUNCTIONAL PS THAN WITH FREE PS |
| |
- |
THROMBOPATH KIT HAS INCREASED SENSITIVITY TO PROTHROMBOTIC LUPUS ANTICOAGULANTS |
| Diaz Ricart M. |
- |
ATS-13 ACTIVITY AS A COMMON MARKER OF THE ENDOTHELIAL DYSFUNCTION DEVELOPING IN THROMBOTIC MICROANGIOPATHIES OF DIFFERENT ORIGIN |
| Díaz-Ricart M. |
- |
FLAVONOIDS INHIBIT PLATELET ADHESION AND AGGREGATION UNDER FLOW: BLOCKADE OF TXA2 RECEPTORS IN PLATELET RICH PLASMA |
| Diaz-Ricart M. |
- |
ENDOTHELIAL DYSFUNCTION IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION |
| |
- |
SEROTONIN ENHANCES THE PROCOAGULANT PROPERTIES AND PLATELET ACTIVATION INDUCED DURING PLATELET UP TAKE OF TISSUE FACTOR |
| DiChiara J. |
- |
EFFECTS OF DIABETES ON THE PREVALENCE OF ASPIRIN RESISTANCE DURING LOW DOSE ASPIRIN THERAPY |
| |
- |
PATIENTS WITH METABOLIC SYNDROME DEMONSTRATE HIGH PLATELET REACTIVITY AND INCREASED PROCOAGULANT MARKERS |
| |
- |
MYONECROSIS IS PREDICTED BY HIGH REACTIVITY TO MULTIPLE PLATELET AGONISTS: A TRANSLATIONAL STUDY OF PATIENTS UNDERGOING STENTING TREATED WITH BIVALIRUDIN AND HIGH DOSE CLOPIDOGREL |
| |
- |
PLATELET FUNCTION MEASURED BY VERIFYNOW IDENTIFIES GENERALIZED HIGH PLATELET REACTIVITY IN ASPIRIN TREATED PATIENTS |
| |
- |
DO WE COMPLETELY UNDERSTAND THE ANTITHROMBOTIC EFFECT OF ASPIRIN? |
| |
- |
SUPERIOR EFFECT OF EPTIFIBATIDE ADDED TO CLOPIDOGREL ON BIOMARKER EXPRESSION DETECTED BY FLUOROKINE MULTI-ANALYTE PROFILING IN PATIENTS UNDERGOING ELECTIVE PCI |
| |
- |
LATE BREAKING CLINICAL TRIAL: BIVALIRUDIN WITH AND WITHOUT EPTIFIBATIDE FOR ELECTIVE STENTING: A PHARMACODYNAMIC STUDY OF PLATELET REACTIVITY IN RELATION TO THE OCCURRENCE OF PERIPROCEDURAL MYOCARDIAL INFARCTION (THE CLEAR PLATELETS-2 STUDY) |
| |
- |
TRANSITION TO AN UNSTABLE CORONARY SYNDROME IS MARKED BY HYPERCOAGUABILITY, PLATELET ACTIVATION, HEIGHTENED PLATELET REACTIVITY, AND INFLAMMATION: RESULTS OF THE THROMBOTIC RISK PROGRESSION (TRIP) STUDY |
| |
- |
EFFECT OF BIVALIRUDIN VS. BIVALIRUDIN WITH EPTIFIBATIDE ON PLATELET ACTIVATION AND AGGREGATION IN PATIENTS RECEIVING CHRONIC CLOPIDOGREL THERAPY UNDERGOING ELECTIVE PCI |
| |
- |
BIOMARKER ANALYSIS BY FLUOROKINE MULTI-ANALYTE PROFILING DISTINGUISHES PATIENTS REQUIRING INTERVENTION FROM PATIENTS WITH LONG-TERM QUIESCENT CORONARY ARTERY DISEASE: A POTENTIAL APPROACH TO IDENTIFY ATHEROSCLEROTIC DISEASE PROGRESSION |
| |
- |
RELATION OF PLATELET-FIBRIN CLOT STRENGTH, PLATELET REACTIVITY, INFLAMMATION AND GROWTH FACTOR RELEASE TO THROMBOTIC RISK IN PATIENTS UNDERGOING STENTING |
| Dick A. |
- |
THERAPEUTIC DRUG MONITORING OF HEPARINS AND DIRECT THROMBIN INHIBITORS: THE GERMAN EXTERNAL QUALITY ASSESSMENT SCHEME |
| Dickneite G. |
- |
COMBINATION THERAPY OF A PORCINE BONE TRAUMA FOLLOWING A DILUTIONAL COAGULOPATHY BY PROTHROMBIN COMPLEX CONCENTRATE (PCC) AND FIBRINOGEN |
| Dickstein Y. |
- |
PERFORMANCE EVALUATION OF THE COAGUCHEK XS SYSTEM IN ROUTINE PATIENT ANTICOAGULATION MANAGEMENT CLINICS IN ISRAEL |
| Diehl J. |
- |
DECREASED ADAMTS-13 IS ASSOCIATED WITH A POOR PROGNOSIS IN SEPSIS-INDUCED ORGAN FAILURE |
| Diehm C. |
- |
INCIDENCE OF DEEP VEIN THROMBOSIS (DVT) IN NON-SURGICAL PATIENTS AT HOSPITAL ADMISSION |
| Dielis A.W.J.H. |
- |
THROMBIN GENERATION AND COAGULATION MARKERS IN PATIENTS WITH A FIRST ACUTE MYOCARDIAL INFARCTION |
| |
- |
THROMBOXANE B2 IN PATIENTS WITH A FIRST ACUTE MYOCARDIAL INFARCTION: THE INFLUENCE OF TREATMENT WITH ACETYLSALICYLIC ACID |
| |
- |
COAGULATION FACTORS AND THE PROTEIN C SYSTEM AS DETERMINANTS OF THROMBIN GENERATION |
| |
- |
LEVELS OF FACTOR VIII (FVIII), D-DIMER AND THROMBIN GENERATION (TG) IN PATIENTS AFTER ACUTE DEEP VEIN THROMBOSIS (DVT) |
| |
- |
THROMBIN GENERATION IN PATIENTS AFTER RECENT DEEP VEIN THROMBOSIS VERSUS HEALTHY CONTROLS |
| |
- |
COMPARISON OF THROMBIN GENERATION AND FVIII LEVEL MEASUREMENTS IN HAEMOPHILIA PATIENTS AFTER RECOMBINANT FACTOR VIII TREATMENT |
| |
- |
IN VIVO AVAILABILITY OF TWO RECOMBINANT FACTOR VIII PRODUCTS |
| Diener J.L. |
- |
DISCOVERY OF A POTENT, DIRECT THROMBIN INHIBITING APTAMER |
| Diener J. |
- |
PHARMACOKINETIC/PHARMACODYNAMIC PROFILE OF A NOVEL APTAMER DIRECT THROMBIN INHIBITOR IN CYNOMOLGUS MONKEYS AND YORKSHIRE PIGS FOLLOWING A SINGLE IV BOLUS ADMINISTRATION |
| Diener J.L. |
- |
AN ANTI-VON WILLEBRAND'S FACTOR A1 DOMAIN APTAMER INHIBITS ARTERIAL THROMBOSIS INDUCED BY ELECTRICAL INJURY IN CYNOMOLGUS MACAQUES |
| |
- |
DISCOVERY AND CHARACTERIZATION OF A POTENT NEUTRALIZING ANTI-VWF A1 DOMAIN SPECIFIC APTAMER |
| |
- |
INHIBITION OF PLATELET FUNCTION BY THE ANTI-VON WILLEBRAND FACTOR APTAMER, ARC1779 |
| Dier K.J. |
- |
ARE ANTIPHOSPHOLIPID ANTIBODIES RISK FACTORS FOR CORONARY ARTERY DISEASE? |
| Dier U. |
- |
INHIBITION OF CANCER AND INFLAMMATION-ASSOCIATED THROMBOSIS USING NOVEL INHIBITORS OF NFKB AND OXIDATIVE STRESS PATHWAYS |
| Diers I.V. |
- |
FXIII VARIANTS WITH ALTERED THROMBIN ACTIVATION RATES |
| Dietrich A. |
- |
UNALTERED CA2+ HOMEOSTASIS AND AGONIST-INDUCED ACTIVATION IN PLATELETS LACKING TRANSIENT RECEPTOR POTENTIAL (TRP) C1 |
| Dieu B. |
- |
RISK FACTOR FOR ORAL ANTICOAGULANT TREATMENT OVERDOSE: A CASE CONTROL STUDY IN AN EMERGENCY UNIT |
| Diez J.M. |
- |
HEPARIN AFFINITY CHROMATOGRAPHY AND ADDITIONAL PURIFICATION STEPS EFFECTIVELY ELIMINATE AN EXPERIMENTAL TSE-MODEL AGENT SPIKED INTO FACTOR VIII/VWF PRODUCTION PROCESS |
| |
- |
NANOFILTRATION APPLIED TO FACTOR IX PURIFICATION PROCESS EFFECTIVELY ELIMINATES AN EXPERIMENTAL TSE-MODEL AGENT |
| Diez Martin J. |
- |
HEPARIN-INDUCED THROMBOCYTOPENIA IN A PATIENT WITH POLYCYTEMIA VERA: A THREATENING ASSOCIATION |
| Dignat-George F. |
- |
PRETERM BIRTH AND FETAL GROWTH RESTRICTION HAVE AN IMPACT ON ELASTIC AND COLLAGENIC STRUCTURES OF HUMAN UMBILICAL ARTERIES |
| |
- |
ENDOTHELIAL PROGENITORS AND CIRCULATING ENDOTHELIAL CELLS: REGENERATION VERSUS DEGENERATION |
| |
- |
VASP PHOSPHORYLATION ANALYSIS PRIOR TO PERCUTANEOUS CORONARY INTERVENTION FOR EXCLUSION OF POST-PROCEDURAL MAJOR ADVERSE CARDIOVASCULAR EVENTS |
| |
- |
THE UREMIC SOLUTE INDOXYL SULFATE INDUCES OXIDATIVE STRESS IN ENDOTHELIAL CELLS |
| |
- |
ENDOTHELIAL MARKERS OF INJURY/REPAIR EQUILIBRIUM IN PATIENTS UNDERGOING CORONARY ANGIOPLASTY |
| |
- |
IMMUNO-MAGNETIC ENRICHMENT FOLLOWED BY MULTI-PARAMETER FLOW CYTOMETRY: A NEW APPROACH TO COUNT CIRCULATING ENDOTHELIAL CELLS |
| |
- |
UNIQUE RECIPROCAL MAP KINASE REGULATION IN THROMBIN-INDUCED ENDOTHELIAL PRO-INFLAMMATORY ACTIVATION |
| |
- |
SHORT-TERM OPTIMIZATION OF GLYCEMIC CONTROL WITH INTENSIVE INSULIN THERAPY DECREASE CIRCULATING PLATELET AND ENDOTHELIAL MICROPARTICLES LEVELS IN TYPE 2 DIABETIC PATIENTS |
| |
- |
COMPLEX MECHANISMS CONTROLLING THE THROMBIN-INDUCED GENERATION OF ENDOTHELIAL MICROPARTICLES |
| Dignat-Georges F. |
- |
STANDARDIZATION OF MICROPARTICLE COUNTING USING FLOW CYTOMETRY: NEW OPTIONS AND TOOLS FOR THE CONTROL OF CRITICAL INSTRUMENT SETTINGS |
| Dikkeschei L.D. |
- |
NOVEL MOLECULAR DEFECT IN THE PLATELET ADP RECEPTOR P2Y12 OF A PATIENT WITH HAEMORRHAGIC DIATHESIS |
| Dikkeschei B. |
- |
INR RESULTS OF THE COAGUCHEK XS PLUS SYSTEM ARE EQUIVALENT TO THOSE OF THE COAGUCHEK XS SYSTEM |
| |
- |
PERFORMANCE OF THE COAGUCHEK XS PLUS SYSTEM USING LIQUID QUALITY CONTROL SAMPLES |
| Dilks J.R. |
- |
A NOVEL FAMILY OF ALKYLATED QUINOLINES INHIBITS G PROTEIN-COUPLED RECEPTORS WITH PALMITOYLATED CYTOPLASMIC TAILS |
| Dillow A. |
- |
RECOMBINANT IL-11 INCREASES VWF AND VWFMRNA IN TYPE 1 VWD |
| Dillow A.M. |
- |
SUCCESSFUL LONG TERM EXPRESSION OF FVIII AFTER GENE DELIVERY OF NOVEL ADENO-ASSOCIATED VIRAL VECTOR SEROTYPES IN HEMOPHILIA A DOGS |
| Dillow A. |
- |
EFFECT OF RFVIIA AND NN1731 (RFVIIA ANALOGUE) ON THROMBOELASTOGRAPHY (TEG) IN WHOLE BLOOD OBTAINED FROM HAEMOPHILIA A DOGS |
| DiMichele D. |
- |
U.S. INHIBITOR PILOT PROJECT: STUDY DESIGN AND METHODS VALIDATION |
| |
- |
IMMUNE TOLERANCE THERAPY FOR FACTOR VIII INHIBITORS: MOVING FROM EMPIRICISM TO AN EVIDENCE - BASED APPROACH |
| Dimichele D.M. |
- |
SEVEN NOVEL MISSENSE MUTATIONS IN THE VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1 (VKORC1) CAUSE HEREDITARY COUMARIN RESISTANCE |
| Dimova S.N. |
- |
LYMPHOCYTE PLATELET ADHESION IN THROMBOPHILIC PATIENTS WITH LUNG SURGERY |
| D'Incà M. |
- |
EFFICACY AND SAFETY OF HIGHLY PURIFIED VWF/FVIII CONCENTRATES IN THE TREATMENT OF INHERITED VON WILLEBRAND DISEASE: RESULTS FROM THE RETROSPECTIVE ITALIAN STUDY ON 103 CASES |
| Dindo D. |
- |
COMPARISON OF THREE METHODOLOGIES TO ASSAY D-DIMER LEVELS IN SURGICAL PATIENTS: D DIMER ON MINIVIDAS VS. TINA-QUANT ON MODULAR P VS. TINA-QUANT ON BEHRING COAGULATION SYSTEM - A CALL FOR STANDARDISATION IN D-DIMER TESTING |
| Ding Q. |
- |
INVESTIGATIONS OF THROMBIN GENERATION TESTS IN WARFARIN-TAKING PATIENTS |
| |
- |
8 NOVEL MUTATIONS IDENTIFIED GLANZMANN THROMBASTHENIA FAMILIES FROM CHINA |
| |
- |
FUNCTIONAL ANALYSES OF THE LEU752ARG AND GLN891STOP ASSOCIATED WITH GLANZMANN THROMBASTHENIA |
| Ding K. |
- |
QUANTITATIVE ANALYSIS OF GENE EXPRESSION FOR VASCULAR ENDOTHELIAL GROWTH FACTOR AND ITS APPLICATION |
| Ding Q. |
- |
A NOVEL DELETION MUTATION (C.1254 DEL33BP OR C.1251DEL33BP) IN THE F13A GENE CAUSING SEVERE FACTOR XIII DEFICIENCY |
| |
- |
FACTOR V MUTATIONS, SER234LEU AND ARG413CYS, ARE ASSOCIATED WITH FACTOR V DEFICIENCY AND A BLEEDING TENDENCY |
| |
- |
THE SCREEN OF INHERITED ANTICOAGULANT PROTEINS DEFICIENCY AMONG NORMAL CHINESE |
| Ding K. |
- |
VEGF-C PROMOTE OF THE GROWTH AND ANGIOGENESIS IN NB4 CELL XENOGRAFT TUMOR |
| Ding Q. |
- |
COMBINED POLYMORPHISM MARKERS FOR CARRIER AND PRENATAL DIAGNOSIS OF HAEMOPHILIA IN CHINA |
| |
- |
RECOMBINATION IN ONE HAEMOPHILIA A FAMILY |
| |
- |
ANTIPHOSPHOLIPID ANTIBODIES ASSOCIATED WITH MULTIPLE COAGULATION FACTOR DEFICIENCY IN SEVEN CHINESE PATIENTS |
| |
- |
HEREDITARY COAGULATION FACTOR XIII DEFICIENCY CAUSED BY A DELETION MUTATION OF F13A GENE |
| |
- |
PREVALENCE OF PROTEIN S (PS), PROTEIN C (PC), ANTITHROMBIN (AT) DEFICIENCY AND ACTIVATED PC RESISTANCE (APC-R) IN THE CHINESE POPULATION |
| Dinger R. |
- |
MONITORING THROMBIN GENERATION IN WHOLE BLOOD BY ELECTROCHEMISTRY - A NEW APPROACH FOR SCREENING THROMBOPHILIC AND HEMOPHILIC RISKS |
| Diniz M. |
- |
RFVIIA IN THE TREATMENT OF GLANZMANN'S THROMBASTHENIA - CASE REPORT |
| Diniz E.M.A. |
- |
NEONATAL THROMBOSIS: A SERIES OF 18 CASES FROM A BRAZILIAN PEDIATRIC CENTER |
| Dinu B. |
- |
PREVALENCE OF "ASPIRIN RESISTANCE" IN CHILDREN |
| DiPaola J. |
- |
U.S. INHIBITOR PILOT PROJECT: STUDY DESIGN AND METHODS VALIDATION |
| DiPAOLA J. |
- |
SAFETY AND EFFICACY OF VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE FOR PROPHYLAXIS DURING ELECTIVE SURGERY IN SUBJECTS WITH VON WILLEBRAND DISEASE |
| DiPaola J. |
- |
VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE EFFECTIVELY PREVENTS EXCESSIVE BLEEDING IN PATEINTS WITH VERY LOW VWF:RCO PLASMA LEVELS |
| Dippel D.W.J. |
- |
ADAMTS13 LEVELS ARE ASSOCIATED WITH THE RISK OF ARTERIAL THROMBOSIS IN YOUNG SUBJECTS |
| Diquattro M. |
- |
IMMUNOGLOBULINE ANTI-D (WINRHO) IN CRHONIC CHILDOOD IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP), ANALYSIS OF "IMMATURE PLATELET FRACTION (I.P.F.)" AND ASYMPTOMATIC THROMBOCYTOPENIA |
| Diringer M.N. |
- |
LATE BREAKING CLINICAL TRIAL: RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER PHASE III STUDY TO ASSESS RFVIIA EFFICACY IN ACUTE INTRACEREBRAL HEMORRHAGE: THE FAST TRIAL |
| Dirksen A. |
- |
MOLECULAR IMAGING OF THROMBI USING A BIMODAL A2-ANTIPLASMIN-BASED CONTRAST AGENT |
| Dirkx S.P.G. |
- |
ALPHA-1-ANTITRYPSIN IS THE MOST ABUNDANT PROTEIN NON-COVALENTLY BOUND TO THE FIBRIN MATRIX OF A PLASMA CLOT |
| Dissanayake M.P. |
- |
MULTIPLE SITES OF FXIIIA ARE INVOLVED IN THE BINDING INTERACTION TO THE ALPHA CHAIN OF FIBRINOGEN |
| Distante A. |
- |
THE OMEGA-3 FATTY ACID DOCOSAHEXAENOATE (DHA) REDUCES CYCLOOXYGENASE(COX)-2 INDUCTION BY INHIBITING NADP(H) OXIDASE AND PKC: POSSIBLE INVOLVEMENT OF 15-LIPOXIGENASE(LO)-1 |
| |
- |
HOMOCYSTEINE INDUCES VCAM-1 GENE EXPRESSION THROUGH NF-KB AND NAD(P)H OXIDASE ACTIVATION: PROTECTIVE ROLE OF MEDITERRANEAN DIET POLYPHENOLIC ANTIOXIDANTS |
| |
- |
THE PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR(PPAR)GAMMA AGONIST ROSIGLITAZONE (RSG) INHIBITS CYCLOOXYGENASE(COX)-2 EXPRESSION BY SUPPRESSING PKCAPLHA AND CREB ACTIVATION |
| |
- |
HYDROXYTYROSOL, THE MAJOR OLIVE OIL PHENOLIC ANTIOXIDANT, REGULATES EXPRESSION AND ACTIVITY OF MATRIX METALLOPROTEINASE(MMP)-9 IN HUMAN MONOCYTOID CELLS - POSSIBLE CONTRIBUTION TO PLAQUE STABILITY |
| Distaso M. |
- |
DEFIBROTIDE MODULATES HEPARANASE EXPRESSION IN ENDOTHELIAL AND TUMOR CELLS: A POTENTIAL MECHANISM OF ACTION |
| Dittrich M. |
- |
ANALYSIS OF THE INTERACTOME IN HUMAN PLATELETS |
| Dix D. |
- |
POST-THROMBOTIC SYNDROME IN CHILDREN SURVIVING ACUTE LYMPHOBLASTIC LEUKEMIA |
| Djaafri I.S. |
- |
THE KOGEOGPK PEPTIDE FROM TYPE III COLLAGEN INHIBITS BREAST ADENOCARCINOMA CELL ADHESION TO TYPE III COLLAGEN AND HUVEC MATRIX IN WHOLE BLOOD AND UNDER FLOW CONDITIONS |
| Djaafri I. |
- |
TYPE III COLLAGEN BINDING PROTEIN (TIIICBP) IS IDENTICAL TO KINDLIN-3, A PROTEIN BELONGING TO A NOVEL FAMILY OF FOCAL ADHESION PROTEINS |
| Djambas Khayat C. |
- |
DETECTION OF 23 NOVEL MUTATIONS IN LEBANESE HEMOPHILIA PATIENTS |
| Djodjevic V. |
- |
PREVALENCE OF THROMBOPHILIA IN WOMEN WITH RECURRENT PREGNANCY LOSS SERBIAN EXPERIENCE |
| Djordjevic V. |
- |
THE 3'UTR PROTHROMBIN GENE POLYMORPHISMS IN THROMBOHILIC SERBIAN POPULATION |
| |
- |
MOLECULAR MARKERS OF BLOOD HYPERCOAGULABILITY IN HETEROZYGOUS CARRIERS OF FACTOR V LEIDEN MUTATION |
| |
- |
RISK FACTORS FOR THROMBOSIS IN CHILDREN |
| Djukic A.L. |
- |
COAGULATION ABNORMALITIES IN WOMEN WITH VERIFIED MENORRHAGIA IS IT TIME FOR INCLUSION OF COAGULATION SCREENING IN DIAGNOSTIC ALGORITHM? |
| Djumhana Atmakusuma T. |
- |
ANTIPHOSPHOLIPID ANTIBODIES IN ADULT -THALASSEMIA |
| |
- |
CORRELATION BETWEEN A HIGHER LEVEL OF ACA WITH THE HEMOSTASIS ABNORMALITIES AMONG ADULT -THALASSEMIA |
| |
- |
POTENTIAL FACTORS WHICH MAY CAUSE A HIGH LEVEL OF ACA IGG AND IGM |
| Djunic I.S. |
- |
EFFEKT OF PARAPROTEINS ON PLATELET AGGREGATION |
| Djurdjevic P. |
- |
COAGULATION ABNORMALITIES IN WOMEN WITH VERIFIED MENORRHAGIA IS IT TIME FOR INCLUSION OF COAGULATION SCREENING IN DIAGNOSTIC ALGORITHM? |
| Dlott J. |
- |
IDENTIFICATION OF VON WILLEBRAND DISEASE TYPE 2N BY VWF-FVIII BINDING ACTIVITY ASSAY IN PATIENTS AND HETEROZYGOUS CARRIERS |
| Dlugai S. |
- |
PROTEIN DISULFIDE ISOMERASE (PDI) UNCOVERS TISSUE FACTOR (TF)-DEPENDENT FIBRIN FORMATION AFTER VESSEL INJURY |
| do Céu Monteiro M. |
- |
ROLE OF PLATELET GLYCOPROTEIN IB-ALPHA POLYMORPHISM IN PLATELET REACTIVITY |
| Dobaczewski M. |
- |
THE METHODOLOGICAL PROBLEMS IN BLOOD PLATELET INVESTIGATION ARE STILL ACTUAL |
| Dobrotova M. |
- |
ACQUIRED HAEMOPHILIA A WITH INHIBITOR - CASE REPORT |
| |
- |
STICKY PLATELET SYNDROME (SPS) AND PLATELET GLYCOPROTEIN POLYMORPHISMS |
| Dobrovolsky A. |
- |
INFLUENCE OF CYP2C9 GENETIC POLYMORPHISMS ON METABOLIC CLEARANCE, WARFARIN MAINTENANCE DOSE AND BLEEDING COMPLICATIONS IN RUSSIAN PATIENTS |
| |
- |
D-DIMER IN PATIENTS WITH CLINICAL SIGNS OF ATHEROTHROMBOSIS IN DIFFERENT VASCULAR BEDS |
| Dochy E. |
- |
IS D-DIMER TESTING COST-EFFECTIVE IN ELDERLY PATIENTS CLINICALLY SUSPECTED OF DEEP VEIN THROMBOSIS? |
| Dodig S. |
- |
INHERITED PROTHROMBOTIC RISK FACTORS IN CHILDREN WITH CEREBROVASCULAR DISORDERS |
| Dodt J. |
- |
DETERMINATION OF PLASMA COAGULATION FACTOR XIII WITH THE NOVEL FLUOROGENIC ISOPEPTIDASE ASSAY |
| Doenges E. |
- |
OPTIMIZATION OF COAGULATION FACTOR ASSAYS FOR IMPROVED ACCURACY OVER AN EXTENDED LINEAR RANGE |
| Doering C.B. |
- |
GENETICALLY-MODIFIED HEMATOPOIETIC STEM CELLS ENCODING PORCINE FACTOR VIII INDUCE PROCOAGULANT ACTIVITY IN HEMOPHILIA A MICE WITH PRE-EXISTING FACTOR VIII IMMUNITY |
| |
- |
IDENTIFICATION OF A CLINICALLY RELEVANT GENE THERAPY STRATEGY TO TREAT HEMOPHILIA A USING A HIGH-EXPRESSION FACTOR VIII VECTOR AND GENETICALLY-MODIFIED HEMATOPOIETIC STEM CELLS |
| Doevendans P.A.F.M. |
- |
THE FACTOR VII ACTIVATING PROTEASE (FSAP) POLYMORPHISM (G534E) IS ASSOCIATED WITH A DECREASED RISK FOR RESTENOSIS AFTER PERCUTANEOUS CORONARY INTERVENTION |
| |
- |
PLATELET RECEPTOR P2Y12 HAPLOTYPES PREDICT RESTENOSIS AFTER PERCUTANEOUS CORONARY INTERVENTIONS |
| Doggen C.J.M. |
- |
LONG DISTANCE TRAVEL AND RISK OF VENOUS THROMBOSIS: EFFECT OF PROCOAGULANT FACTOR LEVELS |
| |
- |
GENETIC VARIATION IN THE CYP4V2 GENE IS ASSOCIATED WITH VENOUS THROMBOSIS |
| |
- |
MODERATE ALCOHOL CONSUMPTION DECREASES THE RISK OF VENOUS THROMBOSIS |
| |
- |
POLYMORPHISMS IN COAGULATION FACTORS ARE NOT ASSOCIATED WITH THE RISK OF RECURRENT MAJOR ARTERIAL CARDIOVASCULAR EVENTS IN MEN AFTER A FIRST MYOCARDIAL INFARCTION: RESULTS OF 11 YEARS FOLLOW-UP |
| |
- |
`IN VIVO' TOLL-LIKE RECEPTOR 4 MRNA LEVELS ARE ASSOCIATED WITH RISK OF MYOCARDIAL INFARCTION IN MEN |
| |
- |
HAPLOTYPES OF THE C-REACTIVE PROTEIN GENE, PLASMA CRP LEVELS AND THE RISK OF MYOCARDIAL INFARCTION IN MEN |
| |
- |
INFLUENCE OF TESTING FOR INHERITED THROMBOPHILIA ON RECURRENCE OF VENOUS THROMBOEMBOLISM |
| |
- |
RECURRENT VENOUS THROMBOSIS OF THE UPPER EXTREMITY |
| |
- |
FACTOR IX MALM IS ASSOCIATED WITH VENOUS THROMBOSIS |
| |
- |
THE EFFECT OF FLIGHT-RELATED BEHAVIOUR ON THE RISK OF VENOUS THROMBOSIS AFTER AIR TRAVEL |
| |
- |
INVESTIGATING POSSIBLE MECHANISMS OF THE FACTOR V LEIDEN PARADOX |
| |
- |
MAJOR CHANGES IN THE DIAGNOSTIC WORK-UP OF PULMONARY EMBOLISM BETWEEN 1999 AND 2004 |
| |
- |
MINOR LEG INJURIES INCREASE VENOUS THROMBOTIC RISK FIVE FOLD |
| |
- |
HYPOFIBRINOLYSIS AS A RISK FACTOR FOR MYOCARDIAL INFARCTION IN MEN |
| |
- |
SYNERGISTIC EFFECTS OF HYPOFIBRINOLYSIS AND GENETIC AND ACQUIRED RISK FACTORS IN VENOUS THROMBOSIS |
| |
- |
SMOKING INCREASES THE RISK OF VENOUS THROMBOSIS |
| |
- |
TRENDS IN THE DIAGNOSTIC WORK-UP OF DEEP VENOUS THROMBOSIS OF THE LEG BETWEEN 1999 AND 2004 |
| |
- |
VENOUS THROMBOSIS IN THE ELDERLY |
| Dogne J.M. |
- |
THROMBIN ACTIVITY PROFILE: A POWERFUL EX VIVO SCREENING TEST FOR THE DEVELOPMENT OF ANTICOAGULANT DRUGS |
| Doh H. |
- |
BIOCHEMICAL ANALYSIS OF RECOMBINANT FIBRINOGEN AALPHAGLN328PRO; PREVIOUSLY REPORTED AS FIBRINOGEN VARIANT SEOUL II WITH IMPAIRED FIBRIN ALPHA-CHAIN CROSS-LINKING |
| Dohmen S.E. |
- |
FVIII-SPECIFIC MEMORY B CELLS IN PATIENTS WITH HEMOPHILIA A |
| d'Oiron R. |
- |
THE RISK OF INHIBITOR DEVELOPMENT IN 1104 PATIENTS WITH HEMOPHILIA A ACCORDING TO FACTOR VIII GENOTYPE |
| Dokou H. |
- |
A HIGH NORMAL VALUE OF PLASMA PROTEIN Z IS AN UNCOMMON FINDING IN NON-ARTERITIC ISCHEMIC OPTIC NEUROPATHY (N-AION) PATIENTS |
| Dolan G. |
- |
TRENDS IN FVIII AND FIX USE IN THE UNITED KINGDOM 2001-2006 |
| |
- |
WARFARIN PHARMACOGENOMICS: A MULTIPLEX METHOD FOR CYP2C9 AND VKORC1 GENOTYPING |
| |
- |
GENETIC ANALYSIS IN HYPOFIBRINOGENEMIA IN ELEVEN FAMILIES |
| |
- |
POTENTIAL ROLE OF RAPID MOLECULAR SCREENING OF PATIENTS WITH DYSFIBRINOGENEMIA |
| Dolce A. |
- |
GYNAECOLOGICAL BLEEDING IN CONGENITAL FACTOR VII DEFICIENCY |
| Dole W.P. |
- |
A NOVEL P2Y12 ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONIST THAT INHIBITS PLATELET AGGREGATION AND THROMBUS FORMATION IN RAT AND DOG MODELS |
| Dolling S. |
- |
RECOMBINANT BBETA-LYS448 IS ASSOCIATED WITH SIGNIFICANT CHANGES IN FIBRIN STRUCTURE AND CLOT RIGIDITY |
| Dolnicar M.B. |
- |
DATABASE ON RARE BLEEDING DISORDER (RBDS): PHENOTYPE AND GENOTYPE ANALYSIS ON 400 AFFECTED PATIENTS |
| Dolores S. |
- |
FIVE PROTHROMBOTIC POLYMORHISMS AND VENOUS THROMBOEMBOLISM |
| Domagala T.B. |
- |
IMPROVEMENT OF THIOLACTONASE ACTIVITY OF PARAOXONASE 1 BY SIMVASTATIN IN PATIENTS WITH CORONARY ARTERY DISEASE |
| |
- |
ANTITHROMBOTIC AND ANTI-PLATELET EFFECTS LIPID-LOWERING DRUGS, HOMOCYSTEINE AND N-METHYLNICOTYNAMIDE PLASMA LEVELS IN PATIENTS WITH HYPERCHOLESTEROLEMIA |
| Domanic N. |
- |
DNA REPAIR GENE XRCC1 AND XPD POLYMORPHISMS AND THEIR ASSOCIATION WITH CORONARY ARTERY DISEASE RISKS AND MICRONUCLEUS FREQUENCY |
| Domingheti C.P. |
- |
FACTOR V LEIDEN (G1691A), PROTHROMBIN (G20210A) AND METILENETETRAHYDROFOLATE |
| |
- |
PLASMINOGEN ACTIVATOR INHIBITOR -1 (PAI-1) PLASMA LEVELS AND 4G/5G AND G844A PAI-1 PROMOTER POLYMORFISMS IN BRAZILIAN PATIENTS WITH ISQUEMIC STROKE AND PERIPHERAL ARTERIAL DISEASE |
| |
- |
APOB/APOA-I RATIO IN PATIENTS WITH ISCHEMIC STROKE (IS) AND PERIPHERAL ARTERIAL DISEASE |
| |
- |
PREVALENCE OF APOLIPOPROTEIN E ALLELES AND ITS ASSOCIATION WITH SERUM LIPID LEVELS IN BRAZILIAN PATIENTS WITH ISCHEMIC STROKE AND PERIPHERAL ARTERIAL DISEASE |
| |
- |
HOMOCYSTEINE PLASMA LEVELS AND MTHFR C677T MUTATION IN PATIENTS WITH CORONARY ARTERIAL DISEASE, ISCHEMIC STROKE AND PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE |
| Domingo N. |
- |
CAPACITY OF SOLVENT-DETERGENT TREATMENT AND NANOFILTRATION APPLIED TO FVIII/VWF AND FIX PURIFICATION PROCESSES TO ELIMINATE EMERGING VIRAL PATHOGENS |
| Dominguez M.P. |
- |
TESTOSTERONE INDUCES PHOSPHORYLATION OF P38 AND JNK IN HUVEC |
| Dominheti C.P. |
- |
SERUM C-REACTIVE PROTEIN PLASMA LEVELS IN PATIENTS WITH ARTERIAL THROMBOSIS |
| Dompeling E.C. |
- |
NOVEL MOLECULAR DEFECT IN THE PLATELET ADP RECEPTOR P2Y12 OF A PATIENT WITH HAEMORRHAGIC DIATHESIS |
| Donadini M. |
- |
BRAIN NATRIURETIC PEPTIDE AS A PRECLINICAL MARKER OF CHRONIC PULMONARY HYPERTENSION IN PATIENTS WITH PULMONARY EMBOLISM |
| |
- |
SPIRAL COMPUTED TOMOGRAPHY IN THE EVALUATION OF THE RESOLUTION OF PULMONARY EMBOLISM AFTER A STANDARD COURSE OF ANTICOAGULATION |
| Donahue D. |
- |
THE PROTECTIVE ROLE OF PROTEIN C IN ENDOTOXIN-INDUCED SHOCK |
| Donald M. |
- |
COAGULATION STUDIES IN PATIENTS PRESENTING WITH HYPOTHERMIA |
| Donati M.B. |
- |
ASSOCIATION OF C-REACTIVE PROTEIN AND WHITE BLOOD CELL COUNT WITH PHYSICAL ACTIVITY IN HEALTHY SUBJECTS |
| |
- |
ASSOCIATION OF C-REACTIVE PROTEIN AND ALCOHOL INTAKE IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION |
| |
- |
INTERLEUKINS GENES TAG-SNP HAPLOTYPES AND RISK OF MYOCARDIAL INFARCTION: A POPULATION BASED CASE-CONTROL STUDY |
| Donati M. |
- |
WHOLE BLOOD PROCOAGULANT ACTIVITY: A POSSIBILE CELLULAR MARKER OF CARDIOVASCULAR RISK? |
| |
- |
THROMBOCYTOPENIA AND CONGENITAL RADIAL DYSPLASIA: A CONTINUUM SPECTRUM OF DISEASES. CASE REPORT |
| Donati M.B. |
- |
TISSUE FACTOR GENE TAG-SNPS AND HAPLOTYPES AND THE RISK OF MYOCARDIAL INFARCTION |
| Donati M. |
- |
LEPTIN INDUCES TISSUE FACTOR EXPRESSION IN HUMAN MONOCYTES |
| |
- |
INHIBITION BY SOY ISOFLAVONES OF HUMAN POLYMORPHONUCLEAR LEUKOCYTE FUNCTION |
| |
- |
DETERMINANTS OF PLATELET AGGREGATE FORMATION WITH EITHER POLYMORPHONUCLEAR LEUKOCYTES OR MONOCYTES IN HUMAN WHOLE BLOOD |
| Donati M.B. |
- |
FIBRIN D-DIMERS IS ASSOCIATED WITH PREVALENT CARDIOVASCULAR EVENTS IN THE MOLI-SANI STUDY |
| |
- |
INTERLEUKIN-1B GENE HAPLOTYPES AND INFLAMMATORY/PROCOAGULANT RESPONSE OF HUMAN MONONUCLEAR CELLS |
| |
- |
ASSOCIATION OF C-REACTIVE PROTEIN, OBESITY AND METABOLIC SYNDROME IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION |
| Doncarli A. |
- |
FACTOR V LEIDEN MUTATION AND TROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) POLYMORPHISMS ARE MILD GENETIC MODIFIERS OF HEMORRHAGIC PHENOTYPE IN HEMOPHILIA |
| Doncheva E. |
- |
FREQUENCIES OF CYP2C9, CYP2C19, CYP1A2, CYP3A4, CYP3A5, MDR1 ALLELIC VARIANTS IN PATIENTS WITH DIFFERENT ACENOCOUMAROL DOSE REQUIREMENTS |
| Donfield S. |
- |
HFE GENE MUTATIONS DO NOT SHOW ASSOCIATIONS WITH HEMOPHILIC ARTHROPATHY |
| Donfield S.M. |
- |
ASSOCIATION BETWEEN A HISTORY OF INHIBITORS AND DELAYS IN SKELETAL MATURATION IN ADOLESCENTS WITH HEMOPHILIA |
| Dong J. |
- |
PURIFIED A2 DOMAIN OF VWF BINDS TO THE ACTIVE CONFORMATION OF VWF AND BLOCKS THE INTERACTION WITH PLATELET GPIB; A NOVEL A2 DOMAIN-DERIVED PEPTIDE INHIBITS VWF-GPIB INTERACTION UNDER HIGH FLOW CONDITIONS |
| Dong N. |
- |
FUNCTIONAL IN VITRO CHARACTERIZATION OF A NOVEL ADAMTS13 MUTATION (R1095W) AND POLYMORPHISM (S903L) |
| |
- |
VEGF-C PROMOTE OF THE GROWTH AND ANGIOGENESIS IN NB4 CELL XENOGRAFT TUMOR |
| Dong J. |
- |
MEASURING MICROPARTICLES: PITFALLS AND MODIFICATIONS |
| Dong N. |
- |
EXPRESSION OF MT1-MMP IN HUMAN VASCULAR ENDOTHELIAL CELL LINES AND THE CONSTRUCTION OF ITS EUKARYOTIC EXPRESSION VECTOR |
| Dong J. |
- |
SHEAR-INDUCED DISULFIDE BOND FORMATION REGULATES ADHESION ACTIVITY OF VON WILLEBRAND FACTOR |
| |
- |
HUMAN VH1-69 GERMLINE GENE ENCODED ANTI-SPACER DOMAIN ANTIBODIES THAT DEVELOP IN PATIENTS WITH ACQUIRED TTP INTERFERE WITH THE BINDING OF ADAMTS13 TO VWF |
| Dong N. |
- |
TWO NOVEL MONOCLONAL ANTIBODIES TO VWFA3 INHIBIT VWF-COLLAGEN AND VWFPLATELET GPIB INTERACTIONS |
| Donina E.V. |
- |
PATHOGENETIC PROPHYLAXIS OF RECCURENT FETAL LOSS SYNDROME IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AND GENETIC THROMBOPHILIA |
| Donnachie E. |
- |
SENSITIVITY TO ACTIVATED PROTEIN C (APC) IS INCREASED DURING THE SECRETORY PHASE OF THE MENSTRUAL CYCLE |
| Donovan J.L. |
- |
LONG-TERM WARFARIN THERAPY IS ASSOCIATED WITH TISSUE CALCIFICATION: INFLUENCE OF TREATMENT DURATION, AGE, AND GENDER |
| |
- |
REDUCTION IN EMERGENCY DEPARTMENT VISITS BY PATIENTS ATTENDING AN ANTICOAGULATION CLINIC |
| Doolittle R.F. |
- |
IDENTIFICATION OF GENETIC SEQUENCES CORRESPONDING TO FACTORS V AND VIII IN A LAMPREY TRACE DATABASE |
| |
- |
PROBING THE BETA-CHAIN HOLE OF FIBRINOGEN WITH SYNTHETIC PENTAPEPTIDES THAT DIFFER ONLY AT THEIR AMINO TERMINI |
| Dopheide S.M. |
- |
IDENTIFICATION OF A NOVEL MECHANISM PROMOTING STATIONARY ADHESION OF DISCOID PLATELETS SHEAR DEPENDENT CONVERSION OF PLATELET TETHERS TO PSEUDOPODIA |
| Dorangeon E. |
- |
PROSPECTIVE EVALUATION OF A SIMPLIFIED SCORE FOR THE PREDICTION OF DISSEMINATED INTRAVASCULAR COAGULATION IN SEPSIS |
| |
- |
SIMPLE COAGULATION TESTS IMPROVE EARLY MORTALITY PREDICTION IN ICU PATIENTS WITH SEPTIC SHOCK |
| Dorling A. |
- |
MODULATION OF DENDRITIC CELL FUNCTION BY TISSUE FACTOR AND COAGUALTION PROTEASES |
| |
- |
THROMBIN PROMOTES ANOMALOUS DIFFERENTIATION OF VASCULAR PROGENITOR CELLS DURING NEOINTIMAL HYPERPLASIA AFTER WIRE-INDUCED INJURY |
| |
- |
NK CELL AND MACROPHAGE INFILTRATION INTO ORGAN XENOGRAFTS IS DEPENDENT ON THROMBIN-MEDIATED PRODUCTION OF MONOCYTE CHEMOTACTIC PROTEIN-1(MCP-1) THROUGH PAR-1 |
| |
- |
NEOINTIMAL CELLS IN WIRE-INJURED ARTERIES HAVE A MIXED ENDOTHELIAL CELL (EC)/VASCULAR SMOOTH MUSCLE CELL (VSMC) PHENOTYPE WHICH IS THROMBIN-DEPENDENT |
| Dorn J. |
- |
INTERLEUKINS GENES TAG-SNP HAPLOTYPES AND RISK OF MYOCARDIAL INFARCTION: A POPULATION BASED CASE-CONTROL STUDY |
| dos Santos A. |
- |
MOLECULAR AND FUNCTIONAL CHARACTERIZATION OF FVIII MUTATIONS IN A FEMALE WITH SEVERE HEMOPHILIA A |
| Doti C. |
- |
PROLONGED DVT PROPHYLAXIS IS BETTER THAN STANDARD PROPHYLAXIS IN MAJOR ABDOMINAL SURGERY: A META-ANALYSIS |
| |
- |
LOW DOSE ANTICOAGULANT TREATMENT FOR PATIENTS WITH PERMANENT VENA CAVAL FILTERS |
| |
- |
EVALUATION OF THROMBIN GENERATION CAPACITY IN PLASMA FROM PATIENTS WITH HIGH LEVELS OF FVIII, FIX OR FXI AND ONE SPONTANEOUS VENOUS THROMBOEMBOLIC EVENT |
| Dotsenko O. |
- |
SEX DIFFERENCE IN PLASMA SENSITIVITY TO TISSUE FACTOR RELATES TO THE LEVELS OF CIRCULATING PLATELET-DERIVED MICROPARTICLES |
| |
- |
CIRCULATING PLATELET-MONOCYTE COMPLEXES AS POTENTIAL BIOMARKERS OF THE OVERALL ATHEROSCLEROSIS LOAD IN MEN WITH AND WITHOUT KNOWN CORONARY ARTERY DISEASE |
| |
- |
AT LOW CONCENTRATIONS OF TISSUE FACTOR, CIRCULATING MICROPARTICLES CAUSE A MARKED SHORTENING OF THE RECALCIFICATION TIMES OF PLASMA FROM NORMAL HEALTHY INDIVIDUALS |
| Dou L. |
- |
THE UREMIC SOLUTE INDOXYL SULFATE INDUCES OXIDATIVE STRESS IN ENDOTHELIAL CELLS |
| Doubek M. |
- |
MUTATED POSITION OF NMHC-A PREDICTS THE NATURAL HISTORY OF MYH9-RELATED DISEASE |
| Douketis J. |
- |
RISK OF VENOUS THROMBOEMBOLISM (VTE) IN FIRST DEGREE RELATIVES (FDRS) OF PATIENTS WITH UNPROVOKED VTE WHO DO NOT HAVE FACTOR V LEIDEN (FVL) OR THE G20210A PROTHROMBIN GENE MUTATION (PGM) |
| |
- |
COMPARISON OF THE 30-DAY INCIDENCE OF ISCHEMIC STROKE AND BLEEDING AFTER MAJOR SURGERY IN PATIENTS WITH AND WITHOUT ATRIAL FIBRILLATION (AF) |
| |
- |
THE RISK OF FATAL PULMONARY EMBOLISM AFTER STOPPING ANTICOAGULANT THERAPY IN PATIENTS WITH VENOUS THROMBOEMBOLISM |
| Douketis J.D. |
- |
THROMBOEMBOLISM AND BLEEDING OUTCOMES OF LOW-MOLECULAR-WEIGHT HEPARIN BRIDGING THERAPY DURING PERI-PROCEDURE WARFARIN INTERRUPTION: PATIENT-LEVEL POOLED DATA OF FOUR COHORT STUDIES |
| Douketis J. |
- |
EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH INR VALUES OF MORE THAN 10.0: RESULTS OF A PROSPECTIVE COHORT STUDY |
| |
- |
EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH ELEVATED INR VALUES: RESULTS OF RANDOMIZED TRIAL EXAMINING CLINICAL OUTCOMES |
| |
- |
UNFRACTIONATED HEPARIN (UFH) OR LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) AS PERIOPERATIVE BRIDGING THERAPY IN PATIENTS WITH MECHANICAL HEART VALVES (MHVS) ON LONG-TERM ORAL ANTICOAGULANTS (OAC): RESULTS FROM THE REGIMEN REGISTRY |
| |
- |
DALTEPARIN THROMBOPROPHYLAXIS IN CRITICALLY ILL PATIENTS WITH SEVERE RENAL INSUFFICIENCY: THE DIRECT STUDY |
| |
- |
VENOUS THROMBOEMBOLIC COMPLICATIONS IN PATIENTS UNDERGOING CHEST SURGERY FOR LUNG OR PLEURAL MALIGNANT DISEASE |
| |
- |
EVALUATION OF THE ACCURACY OF A 99MTC-LABELLED MONOCLONAL ANTIBODY SPECIFIC FOR D-DIMER IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS (DVT) |
| |
- |
LOW MOLECULAR WEIGHT HEPARIN IN PATIENTS WITH RENAL INSUFFICIENCY: ANALYSIS OF ANTI-XA LEVELS AND CREATININE CLEARANCE |
| |
- |
EFFECT OF SURGICAL PROCEDURES AND SPECIFIED RISK FACTORS ON THE INCIDENCE OF PERI-OPERATIVE STROKE IN PATIENTS WITH ATRIAL FIBRILLATION (AF) |
| Doulsri E. |
- |
POTENTIAL FACTORS WHICH MAY CAUSE A HIGH LEVEL OF ACA IGG AND IGM |
| Douma K. |
- |
MOLECULAR IMAGING OF THROMBI USING A BIMODAL A2-ANTIPLASMIN-BASED CONTRAST AGENT |
| Dourisboure R. |
- |
COMPARISON BETWEEN CONVENTIONAL AND AUTOMATED METHODS OF RISTOCETIN COFACTOR ACTIVITY AND VON WILLEBRAND FACTOR ANTIGEN |
| Dova L. |
- |
ON THREE CASES OF INHERITABLE FACTOR VII DEFICIENCY |
| |
- |
A HIGH NORMAL VALUE OF PLASMA PROTEIN Z IS AN UNCOMMON FINDING IN NON-ARTERITIC ISCHEMIC OPTIC NEUROPATHY (N-AION) PATIENTS |
| Dovlatova N.L. |
- |
COMPETITION BETWEEN REVERSIBLE AND IRREVERSIBLE P2Y12 ANTAGONISTS AND ITS INFLUENCE ON ADP-MEDIATED PLATELET ACTIVATION |
| Dowling N.F. |
- |
QUALITY OF LIFE (QOL) EVALUATION IN WOMEN WITH MENORRHAGIA AND ABNORMAL HEMOSTASIS TESTING PARTICIPATING IN A CROSS-OVER STUDY OF INTRANASAL DESMOPRESSIN AND ORAL TRANEXAMIC ACID |
| Dowling N. |
- |
VENOUS THROMBOEMBOLISM, FACTOR V LEIDEN, AND PROTHROMBIN 20210 AMONG AMERICAN CAUCASIANS IN THE GATE STUDY |
| |
- |
LABORATORY CHARACTERISTICS OF WOMEN WITH MENORRHAGIA: A MULTI-SITE U.S. STUDY |
| Dowling N.F. |
- |
THE EFFECT OF INTRANASAL DESMOPRESSIN VS. ORAL TRANEXAMIC ACID ON MENSTRUAL BLOOD LOSS AMONG WOMEN WITH MENORRHAGIA AND ABNORMAL LABORATORY HEMOSTASIS: A MULTICENTER, RANDOMIZED CROSS-OVER STUDY |
| Dowling N. |
- |
ANTIPHOSPHOLIPID ANTIBODY SYNDROME IN THE THROMBOPHILIA PILOT PROJECT |
| |
- |
PULMONARY EMBOLISM, OBESITY, DIABETES, AND HYPERTENSION AMONG AMERICAN CAUCASIANS IN THE GATE STUDY |
| Dowling N.F. |
- |
POLYMORPHISMS IN THE 3'-END OF THE FIBRINOGEN GAMMA GENE AND RISK OF VENOUS THROMBOEMBOLISM IN THE AFRICAN-AMERICAN AND CAUCASIAN POPULATION |
| Dowling N. |
- |
THROMBOSIS AND HEMOSTASIS CENTERS PILOT SITES REGISTRY: THROMBOPHILIA SCREENING IN CHILDREN |
| Downey C. |
- |
INACTIVATION OF ALPHA-1-PROTEASE INHIBITOR DURING CLINICAL SEPSIS-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION IS NOT CONSISTENT WITH INHIBITOR POLYMERIZATION |
| |
- |
THE BIPHASIC APTT WAVEFORM AS A BIOMARKER FOR TARGETING TREATMENT WITH RECOMBINANT ACTIVATED PROTEIN C (APC) |
| Downey H.D. |
- |
IN VIVO EFFECTS OF MURINE AND HUMAN APC |
| Downey C. |
- |
CYTOPROTECTION AND ANTICOAGULATION BY ACTIVATED PROTEIN C ON CIRCULATING MICROPARTICLE-ASSOCIATED ENDOTHELIAL PROTEIN C RECEPTOR |
| Doyle R. |
- |
ARE ANTIPHOSPHOLIPID ANTIBODIES RISK FACTORS FOR CORONARY ARTERY DISEASE? |
| Doyle M. |
- |
OPTIMIZATION OF COAGULATION FACTOR ASSAYS FOR IMPROVED ACCURACY OVER AN EXTENDED LINEAR RANGE |
| Dragani A. |
- |
OXIDATIVE STRESS AND PLATELET ACTIVATION IN SUBJECTS WITH MODERATE HYPERHOMOCYSTEINEMIA DUE TO MTHFR 677 C-T POLYMORPHISM |
| |
- |
HAEMOPHILIA MANAGEMENT THROUGH AN INTER-REGIONAL NETWORK IN MIDDLE ITALY |
| |
- |
TEN NOVEL MUTATIONS IN FXI GENE |
| Drakunov A.V. |
- |
CLINICAL USE OF TEST OF LYMPHOCYTE-PLATELET ADHESION |
| Dreier T. |
- |
A NOVEL COMPLETE HIGH SHEAR RATE ARTERIAL THROMBOSIS AND BLEEDING MODEL IN BABOONS |
| Dremov R.I. |
- |
HYPERHOMOCYSTEINEMIA AND FACTOR V LEIDEN ACT SYNERGISTICALLY INCREASING RISK OF VEIN THROMBOSIS IN NORTH-WESTERN RUSSIA |
| Drenth A.F. |
- |
EVALUATION OF A NEW FUNCTIONAL CLOTTING ASSAY FOR THE MONITORING OF HEPARIN AND HEPARINOID ANTICOAGULANTS BASED ON THROMBIN AND/OR FACTOR XA INHIBITION WITH CLINICAL PATIENT PLASMAS AT THREE UNIVERSITY MEDICAL CENTERS |
| Drenth H.J. |
- |
MANAGEMENT OF AT ACTIVITY LEVELS WITH ANTITHROMBIN ALFA IN HEREDITARY AT DEFICIENT PATIENTS DURING SURGERY |
| |
- |
PREGNANT HEREDITARY ANTITHROMBIN DEFICIENT WOMEN REQUIRE A DISTINCT DOSING STRATEGY FOR THE MANAGEMENT OF AT ACTIVITY LEVELS WITH ANTITHROMBIN ALFA |
| Drenth A. |
- |
GENERIC VERSIONS OF BRANDED LOW MOLECULAR WEIGHT HEPARINS CAN BE DIFFERENTIATED IN BIOLOGIC AND PHARMACOLOGIC ASSAYS |
| Drexler A. |
- |
HYPERCOAGULABILITY IN OVARIAN CANCER REVISITED: A PROSPECTIVE ANALYSIS OF COAGULATION AND PLATELET ACTIVATION MARKERS |
| |
- |
PROSPECTIVE EVALUATION OF LABORATORY TESTS FOR THE DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA |
| Dreyfus M. |
- |
A NEW LEU123 TO PRO MUTATION IN THE FIFTH LEUCINE-RICH REPEAT OF GLYCOPROTEIN IBALPHA IN A BERNARD-SOULIER PATIENT INDUCES DEFECTIVE SHEAR-DEPENDENT CELL ADHESION ON VON WILLEBRAND FACTOR |
| |
- |
A MULTICENTRE PROSPECTIVE OPEN-LABEL STUDY ASSESSING PHARMACOKINETICS, CLINICAL EFFICACY AND SAFETY OF A TRIPLE-SECURED FIBRINOGEN CONCENTRATE: FIBRINOGENE T-I |
| |
- |
ASSESSMENT OF THE PREDICTIVE VALUE OF PFA-100 TM OCCLUSION TIME CONCERNING THE HAEMORRHAGIC RISK OF TRANSPARIETAL NEEDLE LIVER BIOPSY IN CHILDREN |
| Driban J.B. |
- |
ELEVATED PLASMA LEVELS OF THROMBOSPONDIN-1 (TSP1) ARE ASSOCIATED WITH INCREASED LEVELS OF TGF-BETA AND PRO-INFLAMMATORY CYTOKINES IN RHEUMATOID ARTHRITIS PATIENTS |
| Driul L. |
- |
SAFETY AND EFFICACY OF NADROPARIN FOR THE MANAGEMENT OF VENOUS THROMBOEMBOLISM OR THROMBOPHILIA IN PREGNANCY |
| Drizhun Y.S. |
- |
APOE GENE POLYMORPHISM CAN MODIFY THE RISK OF VENOUS THROMBOEMBOLISM |
| Drohan W.N. |
- |
N-GLYCAN SIALYLATION IS IMPORTANT FOR IN VIVO RECOVERY OF RECOMBINANT FACTOR IX |
| Dropinski J. |
- |
THE ADDITIVE ANTIPLATELET ACTION OF CLOPIDOGREL IN PATIENTS WITH CORONARY ARTERY DISEASE TREATED WITH ASPIRIN |
| |
- |
ANTITHROMBOTIC AND ANTI-PLATELET EFFECTS LIPID-LOWERING DRUGS, HOMOCYSTEINE AND N-METHYLNICOTYNAMIDE PLASMA LEVELS IN PATIENTS WITH HYPERCHOLESTEROLEMIA |
| Drouet L. |
- |
DIET MANIPULATION OF ATHEROSCLEROTIC LESIONS IN THE FHD PIG MODEL |
| |
- |
SPECIFIC MULTI-RULE EXPERT SYSTEM FOR ELDERLY INPATIENT ANTICOAGULANT CONTROL |
| |
- |
HCAN CHANGES IN HEMOSTATIC PARAMETERS EXPLAIN THE INCREASED INCIDENCE OF DVT IN ELDERLY ? |
| |
- |
BIOLOGICAL INHIBITION OF PLATELET PROSTAGLANDIN PATHWAY IS NOT MAINTAINED BY LOW DOSE ASPIRIN THROUGHOUT 24 HOURS IN TYPE 2 DIABETIC PATIENTS |
| |
- |
A NEW ANTITHROMBOTIC STRATEGY FOR PATIENTS WITH LONG TERM MECHANICAL CIRCULATORY SUPPORT (MCS) |
| |
- |
RESISTANCE TO OAC ASSOCIATED TO A NEW POINT MUTATION IN VKORC1 GENE |
| |
- |
ABNORMALITIES IN THE SEROTONIN METABOLISM: A PATHOGENIC HYPOTHESIS FOR CENTRAL RETINAL VEIN OCCLUSION (CRVO) |
| |
- |
CYP2C19*2 POLYMORPHISM INFLUENCES PLATELET FUNCTIONNALITY IN RESPONSE TO CLOPIDROGEL TREATMENT |
| |
- |
FUNCTIONAL VARIABILITY OF PLATELET RESPONSE TO CLOPIDOGREL CORRELATES WITH P2Y12 RECEPTOR OCCUPANCY |
| |
- |
PROTEIN Z LEVEL AND GENE POLYMORPHISMS IN MYOCARDIAL INFARCTION IN THE YOUNG |
| |
- |
BLOOD, PLATELET AND ENDOTHELIAL OSTEOPROTEGERIN EXPRESSION IN RELATION WITH ATHEROSCLEROTIC CALCIFICATION IN A MODEL OF GENETICALLY HYPERCHOLESTEROLEMIC PIGS |
| |
- |
D-DIMER AND PROGNOSIS IN PATIENTS WITH CHRONIC ATRIAL FIBRILLATION |
| Drozdova V. |
- |
CLINICAL EXPERIENCE WITH A HIGH PURITY FACTOR IX CONCENTRATE IN YOUNG CHILDREN |
| Drozdowskyj A. |
- |
THE T ALLELE OF THE FXII 46C/T GENE POLYMORPHISM IS RISK FACTOR FOR ICD IN SPANISH POPULATION |
| |
- |
RISK FACTOR PROFILE ASSOCIATED WITH ICD IN SPANISH POPULATION |
| Drugan A. |
- |
COAGULATION PARAMETERS IN AMNIOTIC FLUID DURING HUMAN PREGNANCY ROLE OF TF AND TFPI |
| Druzhinin A. |
- |
CLOT FORMATION AS TREATMENT METHOD FOR PATHOLOGICAL FOCUS: A MATHEMATICAL MODEL |
| Drwila R. |
- |
C-REACTIVE PROTEIN, LIPOPROTEIN(A) AND HOMOCYSTEINE AS CONTRIBUTORS TO FIBRIN CLOT PERMEABILITY AND LYSABILITY IN SUBJECTS SCHEDULED FOR CORONARY ARTERY BYPASS GRAFTING |
| Dryga O. |
- |
MUTATIONS AT THE LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) BINDING SITE OF THE FVIII A2 DOMAIN DID NOT REDUCE LRP BINDING OR INCREASE HALF-LIFE OF NON-ACTIVATED FVIII |
| Du L.M. |
- |
CORRECTION OF HAEMORRHAGIC DISORDERS AFFECTING PLATELETS: GENE THERAPY RESTORES HEMOSTASIS WITHIN A CANINE MODEL FOR GLANZMANN THROMBASTHENIA |
| Du X. |
- |
TALIN HEAD-ROD INTERACTION MODULATES INTEGRIN BINDING TO THE TALIN HEAD DOMAIN |
| Du W. |
- |
SERUM BAFF LEVELS IN PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA |
| Duarte P. |
- |
ASSESSMENT OF THE EFFECTIVENESS AND SECURITY OF HOME TREATMENT OF DEEP VENOUS THROMBOSIS WITH LOW MOLECULAR WEIGHT HEPARIN IN ARGENTINA |
| Dubart A. |
- |
A DECISION SUPPORT TOOL ON HANDELD COMPUTERS TO IMPROVE DIAGNOSTIC STRATEGIES OF PULMONARY EMBOLISM IN EMERGENCY DEPARTMENTS (SPEED STUDY) |
| Dubick M.A. |
- |
THE DIFFERENTIAL EFFECTS OF ACIDOSIS ON FIBRINOGEN SYNTHESIS AND DEGRADATION IN PIGS |
| Dubinsky W.P. |
- |
DYSREGULATION OF ALTERNATIVE SPLICING OF COAGULATION FACTOR V RESULTS IN BLEEDING DISORDER, EAST TEXAS TYPE (OMIM 605913) |
| Dubois B.V. |
- |
LATE BREAKING CLINICAL TRIAL: BIVALIRUDIN WITH AND WITHOUT EPTIFIBATIDE FOR ELECTIVE STENTING: A PHARMACODYNAMIC STUDY OF PLATELET REACTIVITY IN RELATION TO THE OCCURRENCE OF PERIPROCEDURAL MYOCARDIAL INFARCTION (THE CLEAR PLATELETS-2 STUDY) |
| Dubois C. |
- |
THROMBIN-INITIATED PLATELET ACTIVATION IN VIVO IS VON WILLEBRAND FACTOR INDEPENDENT DURING THROMBUS FORMATION IN A LASER INJURY MODEL |
| |
- |
BSDL INTERACTS WITH THE PLATELET CXCR4 AND MODULATES THROMBUS FORMATION |
| Dubois P. |
- |
EVALUATION OF THE BEHAVIOR OF (QUATERNIZED) POLY[(2-DIMETHYLAMINO)ETHYL METHACRYLATE] AND (CROSSLINKED) N-CARBOXYETHYLCHITOSAN AND THEIR COMPLEXES IN CONTACT WITH BLOOD |
| Duboscq C. |
- |
EVALUATION OF THROMBIN GENERATION CAPACITY IN PLASMA FROM PATIENTS WITH HIGH LEVELS OF FVIII, FIX OR FXI AND ONE SPONTANEOUS VENOUS THROMBOEMBOLIC EVENT |
| |
- |
LOW DOSE ANTICOAGULANT TREATMENT FOR PATIENTS WITH PERMANENT VENA CAVAL FILTERS |
| |
- |
PROLONGED DVT PROPHYLAXIS IS BETTER THAN STANDARD PROPHYLAXIS IN MAJOR ABDOMINAL SURGERY: A META-ANALYSIS |
| Duca M. |
- |
EVALUATION OF THE NEW KIT HEMOSIL D-DIMER HS ON SEVERAL INSTRUMENTS COMPARED TO OTHER TURBIDIMETRIC AND ELISA METHODS |
| Duchaussoy P. |
- |
SYNTHESIS AND PROPERTIES OF BIOTINYLATED ANTITHROMBOTIC OLIGOSACCHARIDES |
| |
- |
IN VITRO AND EX VIVO PROPERTIES OF LONG-ACTING REVERSIBLE OLIGOSACCHARIDES |
| |
- |
SULFATION OF THE 3-HYDROXYL GROUP OF THE REDUCING UNIT (H) ON ALKYLATED SULFATED PENTASACCHARIDE IS RESPONSIBLE FOR A HIGH AFFINITY FOR ANTITHROMBIN AND LONGER HALF LIFE IN ANIMALS |
| |
- |
REVERSIBLE BIOTINYLATED OLIGOSACCHARIDES: A NEW APPROACH FOR A BETTER MANAGEMENT OF THE ANTICOAGULANT THERAPY |
| |
- |
ANTITHROMBOTIC ACTIVITIES IN PHARMACOLOGICAL MODELS OF A LONG-ACTING REVERSIBLE SYNTHETIC OLIGOSACCHARIDE |
| Duchemin J. |
- |
VKORC1 GENETIC POLYMORPHISM IS ASSOCIATED TO VENOUS THROMBOEMBOLISM: RESULTS FROM THE EDITH STUDY |
| |
- |
DETECTING PROTHROMBOTIC STATES USING A THROMBIN GENERATION TEST IN RELATIVES OF PATIENTS WITH VENOUS THROMBOEMBOLISM AND FACTOR V LEIDEN |
| Duchini F. |
- |
CANOLA OIL, BUT NOT SUNFLOWER OIL, DECREASES CHOLESTEROL AND IMPROVES ENDOTHELIAL FUNCTION IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE: A DOUBLE-BLIND, RANDOMIZED INTERVENTIONAL STUDY |
| Dücker I. |
- |
FVIII CONCENTRATES OF RECOMBINANT ORIGIN SHOW A HIGHER THROMBIN SENSITIVITY THAN PLASMA-DERIVED FVIII CONCENTRATES BUT NEARLY IDENTICAL APC-MEDIATED INACTIVATION KINETICS |
| Ducloy-Bouthors A. |
- |
ROTEM THROMBOELASTOMETRY IN OBSTETRIC: NEAR PATIENT-TEST AS AN EARLY PREDICTOR OF POST-PARTUM HEMORRHAGE (PPH) |
| Ducouret G. |
- |
PLATELET FACTOR 4 (PF4/CXCL4) SEALS BLOOD CLOTS BY ALTERING THE STRUCTURE OF FIBRIN |
| Ducout L. |
- |
IS PROTEIN S (PS) DEFICIENCY RARER IN THE BASQUES ? |
| Ducros E. |
- |
BASAL EXPRESSION OF ENDOTHELIAL CELL PROTEIN C RECEPTOR IS REGULATED BY ENDOGENOUS ALDOSTERONE, PRODUCED VIA ALDOSTERONE SYNTHASE |
| |
- |
HUMAN MALIGNANT CELLS EXPRESS FUNCTIONALLY ACTIVE ENDOTHELIAL PROTEIN C RECEPTOR |
| |
- |
UP-REGULATION OF ACTIVATED PROTEIN-C RECEPTOR ON HUMAN ENDOTHELIAL CELLS BY ALDOSTERONE |
| Ducruet T. |
- |
PERSISTENT VENOUS SYMPTOMS AND SIGNS 1 MONTH AFTER A FIRST DIAGNOSIS OF DVT PREDICT DEVELOPMENT OF THE POST-THROMBOTIC SYNDROME (PTS) DURING 2 YEARS FOLLOW-UP |
| Dudbridge F. |
- |
PROTEOMIC ANALYSIS OF PLATELET DETERGENT-RESISTANT MEMBRANES FROM HEALTHY HUMAN DONORS WITH "EXTREME-END" RESPONSES TO COLLAGEN-RELATED PEPTIDE AND ADP |
| |
- |
ANALYSING PLATELET FUNCTION FOR FUNCTIONAL GENOMIC STUDIES |
| |
- |
A COMPREHENSIVE STUDY OF CANDIDATE GENES IN TWO SIGNALLING PATHWAYS TO IDENTIFY GENETIC VARIANTS THAT REGULATE PLATELET RESPONSIVENESS TO COLLAGEN AND ADP |
| |
- |
THE EFFECT OF APHERESIS ON DONORS' PLATELETS |
| Dudbridge F.P. |
- |
DIFFERENCES IN PLATELET RESPONSE TO ADP AND CRP ARE CORRELATED WITH VARIATION IN THE RESTING PLATELET TRANSCRIPTOME |
| Duecker I. |
- |
FACTOR VIII CONCENTRATES OF RECOMBINANT ORIGIN SHOW A HIGHER SUSCEPTIBILITY TO THROMBIN PROTEOLYSIS THAN PLASMA-DERIVED CONCENTRATES BUT NEARLY IDENTICAL INACTIVATION RATES BY ACTIVATED PROTEIN C |
| Dufour C. |
- |
MUTATED POSITION OF NMHC-A PREDICTS THE NATURAL HISTORY OF MYH9-RELATED DISEASE |
| |
- |
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA (CAMT): CLINICAL AND BIOLOGICAL CHARACTERIZATION OF FIVE NEW MUTATIONS |
| Duga S. |
- |
DATABASE ON RARE BLEEDING DISORDER (RBDS): PHENOTYPE AND GENOTYPE ANALYSIS ON 400 AFFECTED PATIENTS |
| |
- |
A NOVEL MECHANISM FOR CONGENITAL AFIBRINOGENEMIA BASED ON PSEUDOEXON ACTIVATION IN THE FIBRINOGEN GAMMA-CHAIN GENE |
| |
- |
MISSENSE MUTATIONS IN THE COILED-COIL REGION OF FIBRINOGEN AALPHA CHAIN CAUSE FIBRINOGEN DEFICIENCY BY IMPAIRING DIMERIZATION OF TRIMERIC INTERMEDIATES |
| |
- |
ALTERNATIVE SPLICING AND NONSENSE-MEDIATED DECAY IN THE F5 GENE |
| |
- |
TEN NOVEL MUTATIONS IN FXI GENE |
| |
- |
CHARACTERIZATION OF THE F11 ALTERNATIVE SPLICING PATTERN: IDENTIFICATION OF A NOVEL COAGULATION FXI ISOFORM |
| |
- |
SIMULTANEOUS GENOTYPING OF FXI TYPE II AND TYPE III MUTATIONS BY MULTIPLEX REAL-TIME PCR IN HEALTHY ITALIANS AND IN FXI-DEFICIENT PATIENTS |
| Duggan C. |
- |
AN EVALUATION OF A PHARMACY INPATIENT ANTICOAGULATION SERVICE IN GENERAL & EMERGENCY MEDICINE |
| Duits A.J. |
- |
ENDOGENOUS THROMBIN POTENTIAL, TISSUE FACTOR ANTIGEN LEVELS AND FIBRINOLYSIS IN SICKLE CELL PATIENTS WITH AND WITHOUT PULMONARY HYPERTENSION |
| Dukart H. |
- |
GENETICALLY-MODIFIED HEMATOPOIETIC STEM CELLS ENCODING PORCINE FACTOR VIII INDUCE PROCOAGULANT ACTIVITY IN HEMOPHILIA A MICE WITH PRE-EXISTING FACTOR VIII IMMUNITY |
| Dulicek P. |
- |
CONFIRMATION OF EFFICACY, SAFETY AND COST EFFECTIVENESS OF FRAXIPARINE FORTE IN THE OUTPATIENT TREATMENT OF DEEP VENOUS THROMBOSIS |
| |
- |
ACETYLSALICYLIC ACID (ASA) RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE (IHD) AS BIOINDICATOR OF THE TREATMENT STRATEGY |
| |
- |
FREQUENCY OF F II20210A IN WOMEN WITH VENOUS THROMBOEMBOLISM IN ASSOCIATION WITH ORAL CONTRACEPTIVE USE |
| Dulitzki M. |
- |
PERINATAL ISCHEMIC STROKE AND THE INCIDENCE OF MATERNAL AND NEONATAL THROMBOPHILIA |
| Duman Y. |
- |
RADIOISOTOPE SYNOVECTOMY WITH RHENIUM 186 FOR TREATMENT OF HEMOPHILIC SYNOVITIS |
| Dumont B. |
- |
EX VIVO ANTITHROMBOTIC EFFECTS OF ANTI GPVI FAB FRAGMENT IN NON-HUMAN PRIMATES WITHOUT MODIFICATION OF GPVI EXPRESSION |
| |
- |
COORDINATED ACTION OF GPVI AND FCRGAMMA CYTOPLASMIC DOMAINS IN SIGNALLING |
| Duncan E.M. |
- |
EVALUATION OF A PRE-TEST CLINICAL SCORE FOR THE DIAGNOSIS OF HIT |
| |
- |
LABORATORY DIAGNOSIS OF THE DISCREPANT PHENOTYPE OF MILD HAEMOPHILIA A USING A MODIFIED CHROMOGENIC FACTOR VIII ASSAY |
| Duncan M. |
- |
PROSPECTIVE EVALUATION OF LABORATORY TESTS FOR THE DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA |
| Dunkler D. |
- |
A HIGH PLATELET COUNT INDEPENDENTLY PREDICTS VENOUS THROMBOEMBOLISM IN CANCER PATIENTS |
| |
- |
PLATELET FUNCTION UNDER HIGH SHEAR CONDITION CORRELATES WITH CLINICAL ESTIMATION OF HEMORRHAGE IN CHRONIC AUTOIMMUNE THROMBOCYTOPENIA |
| Dunkley S. |
- |
EFFECTS ON PLATELET AND LEUCOCYTE FUNCTION BY INTRAVENOUS CHINESE MEDICINE WIDELY USED FOR PATIENTS WITH ISCHAEMIC DISEASE IN CHINA |
| |
- |
THE HAEMOSTASIS REGISTRY AUSTRALIAN AND NEW ZEALAND EXPERIENCE WITH RFVIIA |
| Dunn R. |
- |
DIFFERENCES IN PLATELET RESPONSE TO ADP AND CRP ARE CORRELATED WITH VARIATION IN THE RESTING PLATELET TRANSCRIPTOME |
| Dunn A.S. |
- |
UNFRACTIONATED HEPARIN (UFH) OR LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) AS PERIOPERATIVE BRIDGING THERAPY IN PATIENTS WITH MECHANICAL HEART VALVES (MHVS) ON LONG-TERM ORAL ANTICOAGULANTS (OAC): RESULTS FROM THE REGIMEN REGISTRY |
| Dunn R. |
- |
A COMPREHENSIVE STUDY OF CANDIDATE GENES IN TWO SIGNALLING PATHWAYS TO IDENTIFY GENETIC VARIANTS THAT REGULATE PLATELET RESPONSIVENESS TO COLLAGEN AND ADP |
| Dunn A.L. |
- |
INCIDENCE OF LEUKEMIA IN PATIENTS WITH HEMOPHILIA |
| Dunn R. |
- |
PROTEOMIC ANALYSIS OF PLATELET DETERGENT-RESISTANT MEMBRANES FROM HEALTHY HUMAN DONORS WITH "EXTREME-END" RESPONSES TO COLLAGEN-RELATED PEPTIDE AND ADP |
| Dunn A.S. |
- |
THROMBOEMBOLISM AND BLEEDING OUTCOMES OF LOW-MOLECULAR-WEIGHT HEPARIN BRIDGING THERAPY DURING PERI-PROCEDURE WARFARIN INTERRUPTION: PATIENT-LEVEL POOLED DATA OF FOUR COHORT STUDIES |
| Dunn C.R. |
- |
IMPACTS OF GENETIC TESTING FOR THROMBOPHILIA ON FIRST DEGREE RELATIVES OF PATIENTS WITH VENOUS THROMBOEMBOLISM AND A THROMBOPHILIA - A CROSS-SECTIONAL SURVEY |
| |
- |
PSYCHOLOGICAL IMPACTS OF GENETIC TESTING FOR THROMBOPHILIA ON FIRST DEGREE RELATIVES OF PATIENTS WITH VENOUS THROMBOEMBOLISM AND A THROMBOPHILIA A PILOT STUDY |
| Dunne E. |
- |
A NOVEL ROLE FOR CADHERIN 6 IN PLATELET FUNCTION |
| Dunoyer-Geindre S. |
- |
FLUVASTATIN INHIBITS REGULATED SECRETION OF ENDOTHELIAL CELL VON WILLEBRAND FACTOR IN RESPONSE TO DIVERSE SECRETAGOGUES |
| |
- |
THE REGULATION OF ENDOTHELIAL CELL T-PA PRODUCTION BY FLUVASTATIN |
| |
- |
ANTIPHOSPHOLIPID ANTIBODIES AND TLR2 COLOCALIZED IN HUVEC ENDOSOMES |
| |
- |
DIFFERENCES IN ENDOTHELIAL CELL ACTIVATION BY IGG FROM PATIENTS WITH THE ANTIPHOSPHOLIPID SYNDROME OR WITH IMMUNE THROMBOCYTOPENIC PURPURA |
| Duong Van Huyen J. |
- |
BONE MARROW-DERIVED MONONUCLEAR CELL THERAPY INDUCES DISTAL ANGIOGENESIS AFTER LOCAL INJECTION IN CRITICAL LEG ISCHEMIA |
| Dupont C. |
- |
IN VITRO SIMULATION OF BRIDGING THERAPY WITH LMWH AND VITAMIN K ANTAGONISTS. EFFECT ON THROMBIN GENERATION |
| |
- |
BRIDGING THERAPY IN PATIENTS TREATED WITH LMWH AND COUMARIN INDUCES DEEP INHIBITION OF THROMBIN GENERATION |
| Dupré T. |
- |
A ROLE FOR PLATELET ACTIVATION IN LACUNAR STROKE? |
| Duran E. |
- |
INCIDENCE OF ANTI-HEPARIN/PLATELET FACTOR 4 (AHPF4) ANTIBODIES AND HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) IN MEDICAL PATIENTS |
| Duranovic V. |
- |
INHERITED PROTHROMBOTIC RISK FACTORS IN CHILDREN WITH CEREBROVASCULAR DISORDERS |
| Durante C. |
- |
HYPERHOMOCYSTEINEMIA AND THROMBOSIS: THE DIAGNOSTIC ROLE OF POST METHIONINE-LOAD TEST |
| |
- |
CEREBROVASCULAR THROMBOSIS DURING ESTROPROGESTINIC THERAPY IN A YOUNG WOMAN |
| Duranti M. |
- |
HELICAL COMPUTED TOMOGRAPHY TO ASSESS RIGHT VENTRICULAR DYSFUNCTION IN PATIENTS WITH ACUTE PULMONARY EMBOLISM |
| Durbin S. |
- |
MONITORING OF LOW MOLECULAR WEIGHT HEPARIN NADROPARIN DURING HEMODIALYSIS |
| Durham J.D. |
- |
A THROMBOLYTIC REGIMEN FOR HIGH-RISK DEEP VENOUS THROMBOSIS MAY SUBSTANTIALLY REDUCE THE RISK OF POST-THROMBOTIC SYNDROME IN CHILDREN |
| Durieux P. |
- |
A DECISION SUPPORT TOOL ON HANDELD COMPUTERS TO IMPROVE DIAGNOSTIC STRATEGIES OF PULMONARY EMBOLISM IN EMERGENCY DEPARTMENTS (SPEED STUDY) |
| Durin A. |
- |
EFFICACY AND SAFETY OF A SOLVENT-DETERGENT TREATED AND 15-NM FILTERED HUMAN COAGULATION FACTOR IX IN PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HAEMOPHILIA B |
| Düring C. |
- |
ROLE OF ELEVATED ALPHA2-MACROGLOBULIN REVISITED: RESULTS OF A CASE-CONTROL STUDY IN CHILDREN WITH SYMPTOMATIC THROMBOEMBOLISM |
| Duru F. |
- |
CEREBRAL THROMBOSIS ASSOCIATED WITH HETEROZYGOUS FV LEIDEN MUTATION AND HIGH LIPOPROTEIN A LEVEL IN A GIRL WITH FACTOR XIII DEFICIENCY |
| Durukan Tosun M. |
- |
INTRACRANIAL THROMBOSIS COMPLICATING THE MANAGEMENT OF HEMOPHILIC ARTHROPATHY: ANTICOAGULANT TREATMENT IN A CASE WITH HEMOPHILIA B |
| |
- |
USAGE OF FACTOR VIIA IN A CASE OF HEMORRHAGIC CYSTITIS DEVELOPED SECONDARY TO CHEMOTHERAPY |
| Dusek L. |
- |
EFFECT OF THE FIRST DOSE SIZE OF RECOMBINANT FACTOR VIIa ON TREATMENT EFFICACY OF FREQUENT JOINT BLEEDS IN PATIENT WITH HAEMOPHILIA A AND INHIBITOR |
| Dusse L.M.S. |
- |
PREVALENCE OF APOLIPOPROTEIN E ALLELES AND ITS ASSOCIATION WITH SERUM LIPID LEVELS IN BRAZILIAN PATIENTS WITH ISCHEMIC STROKE AND PERIPHERAL ARTERIAL DISEASE |
| |
- |
APOB/APOA-I RATIO IN PATIENTS WITH ISCHEMIC STROKE (IS) AND PERIPHERAL ARTERIAL DISEASE |
| |
- |
HOMOCYSTEINE PLASMA LEVELS AND MTHFR C677T MUTATION IN PATIENTS WITH CORONARY ARTERIAL DISEASE, ISCHEMIC STROKE AND PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE |
| |
- |
PLASMA THROMBOMODULIN IN PRE-ECLAMPSIA |
| |
- |
SERUM C-REACTIVE PROTEIN PLASMA LEVELS IN PATIENTS WITH ARTERIAL THROMBOSIS |
| |
- |
PLASMINOGEN ACTIVATOR INHIBITOR -1 (PAI-1) PLASMA LEVELS AND 4G/5G AND G844A PAI-1 PROMOTER POLYMORFISMS IN BRAZILIAN PATIENTS WITH ISQUEMIC STROKE AND PERIPHERAL ARTERIAL DISEASE |
| |
- |
PLASMINOGEN ACTIVATOR INHIBITOR-1 4G/5G POLYMORPHISM IN CORONARY ARTERY DISEASE AND ITS ASSOCIATION WITH PLASMA PAI-1 LEVELS |
| |
- |
TISSUE FACTOR AND TOTAL TISSUE FACTOR PATHWAY INHIBITOR LEVELS IN CORONARY ARTERY DISEASE: CORRELATION WITH THE SEVERITY OF ATHEROMATOSIS |
| |
- |
TFPI PLASMA LEVELS IN WOMEN WITH PRE-ECLAMPSIA |
| |
- |
FACTOR V LEIDEN (G1691A), PROTHROMBIN (G20210A) AND METILENETETRAHYDROFOLATE |
| |
- |
APO B ECORI AND INSERTION/DELETION POLYMORPHISMS IN BRAZILIAN YOUNG PATIENTS WITH ISQUEMIC STROKE |
| |
- |
PREVALENCE OF POLYMORPHISMS IN EXONS 6 E 7 OF ABO LOCUS AND THEIR ASSOCIATION WITH VENOUS THROMBOSIS IN YOUNG BRAZILIAN PATIENTS |
| Dutour A. |
- |
DISRUPTION OF PAI-1 CIRCADIAN RHYTHM IN OBESE SUBJECTS MAY EXPLAIN A CHANGE IN THE TIME OF ONSET OF MYOCARDIAL INFARCTION |
| |
- |
SHORT-TERM OPTIMIZATION OF GLYCEMIC CONTROL WITH INTENSIVE INSULIN THERAPY DECREASE CIRCULATING PLATELET AND ENDOTHELIAL MICROPARTICLES LEVELS IN TYPE 2 DIABETIC PATIENTS |
| Dutt T. |
- |
THE BIPHASIC APTT WAVEFORM AS A BIOMARKER FOR TARGETING TREATMENT WITH RECOMBINANT ACTIVATED PROTEIN C (APC) |
| Duval-Deverloy A. |
- |
BIOLOGICAL ASSAY OF ASPIRIN-RESISTANCE: ULTRASTRUCTURE OF PLATELET GLYCOPROTEIN REDISTRIBUTION AFTER ARACHIDONIC ACID ACTIVATION AND ASPIRIN INHIBITION, AND COMPARISON WITH USUAL LABORATORY TESTS |
| Duysebekov M.M. |
- |
CLINICAL USE OF TEST OF LYMPHOCYTE-PLATELET ADHESION |
| Dvoryashina I. |
- |
INTERRELATION BETWEEN GENETIC POLYMORPHISM OF HEMOSTATIC SYSTEM AND CORONARY HEART DISEASE IN PATIENTS WITH OBESITY UNDERWENT CORONARY ARTERY BYPASS GRAFTING |
| Dwyer K. |
- |
INCREASED CD39 EXPRESSION PROTECTS KIDNEYS FROM ISCHEMIA REPERFUSION INJURY VIA A REDUCTION IN INFILTRATING CD4+T CELLS: PROTECTION IS AFFORDED BY BOTH EXPRESSIONS ON EITHER TISSUE OR ON CELLULAR BLOOD |
| |
- |
MICE TRANSGENIC FOR THROMBOMODULIN EXHIBIT PROTECTION FROM VENOUS THROMBOSIS |
| Dyck J. |
- |
RISK FACTORS AND OUTCOME OF THROMBOEMBOLIC EVENTS IN CHILDREN UNDERGOING CARDIAC SURGERY |
| Dyer T.D. |
- |
GENETIC DETERMINANTS OF NORMAL VARIATION IN ADAMTS-13 LEVELS: HERITABILITY ESTIMATE AND GENOME-WIDE SCAN |
| Dyr J.E. |
- |
NEW HEREDITARY DYSFIBRINOGENEMIA AALPHA ASN106ASP ASSOCIATED WITH THROMBOSIS |
| Dziedzina S. |
- |
THE ADDITIVE ANTIPLATELET ACTION OF CLOPIDOGREL IN PATIENTS WITH CORONARY ARTERY DISEASE TREATED WITH ASPIRIN |
| Dzierzak E.A. |
- |
HEMATOPOIETIC STEM CELL LOCALIZATION IN EMBRYONIC VASCULATURE |
| Dzsudzsak E. |
- |
GENERATION AND EXPRESSION OF RECOMBINANT FACTOR XIII-B MUTANTS |